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ABSTACT 
Amblyopia is the most common visual disorder in children and is potentially curable if 
detected early and treated properly in the first few years of life. Amblyopia is the leading cause 
of monocular vision loss in children (Bradfield, 2013). It is a developmental neuroplasticity which 
derives from birth causing structural and functional changes in the eye and brain. With this 
structural and functional disruption, visual blur occurs due to refractive amblyopia, strabismic 
amblyopia, cataracts (form-deprivation amblyopia), or a combination of any of these (Solebo, 
Cumberland, & Rahi, 2015). Refractive errors related to amblyopia can also occur. The purpose 
of this evidence-based practice project was to determine if screening a pediatric population 
ages 9 months, 24 months, 36 months, and 48 months using an automated visual screener 
would affect the number of refractive errors detected. The Stetler Model’s stepwise process for 
gathering sound evidence was used to guide this evidence-based practice project at a busy 
Midwest pediatric clinic. Anyone that failed the screening was referred to ophthalmology for 
further testing. Post-intervention group data were collected on patients from the designated age 
groups receiving visual screening during a well-child check-up by two designated providers over 
a three-month period. Pre-intervention group data were collected from electronic health records 
for patients in the same designated age group receiving a well-child check-up by the same two 
providers as post-intervention data over a three-month period. Data were analyzed using 
Pearson’s Chi-Square Goodness of Fit test in an effort to show the sensitivity and specificity of 
the automated visual screener to screen for amblyopic risk factors. Of the total sample size (N = 
322), there were 161 in the pre-implementation group and 161 in the post-implementation 
group. Results supported the PlusOptix™ S12 vision screener in identifying more refractive 
errors than traditional visual exams performed during routine well child check-ups (χ2 = 20.184a, 
p < 0.001, 99% CI). 
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CHAPTER 1 
INTRODUCTION 
Background 
Amblyopia is the most common visual disorder in children and is potentially curable if 
detected early and treated properly in the first few years of life. Amblyopia is the leading cause 
of monocular vision loss in children (Bradfield, 2013). According to Bradfield (2013), Amblyopia 
“is defined as reduced best-corrected visual acuity caused by abnormal visual development” (p. 
348). It is a developmental neuroplasticity which derives from birth and causes structural and 
functional changes in the eye and brain. With this structural and functional disruption, visual blur 
occurs due to refractive amblyopia, strabismic amblyopia, cataracts (form-deprivation 
amblyopia), or a combination of any of these (Solebo, Cumberland, & Rahi, 2015).  Refractive 
errors related to amblyopia include myopia (nearsightedness), hyperopia (farsightedness), and 
astigmatism (abnormal curvature of the cornea). Another serious cause of visual blur and of 
great importance to detect as early as possible is retinoblastoma. “Retinoblastoma is the most 
common intraocular tumor of childhood and seventh most common pediatric malignancy” 
(Hered, 2011, p. 77).  
The US Preventive Services Task Force (USPSTF) statement recommends vision 
screening at least once between the ages 3 and 5 (2011). The USPSTF also states that 
detection and treatment of amblyopia and amblyopic risk factors in children between ages 3 to 5 
years of age leads to great improvement of visual acuity (Mu, et al. 2016; USPSTF 2011). 
According to the USPSTF there has not been sufficient evidence to assess the benefits or 
harms of vision screening earlier than age 3. However, the American Academy of Pediatrics 
(AAP) (2003), and American Association of Pediatric Ophthalmology and Strabismus (AAPOS) 
(2003), recommend early childhood screenings starting in newborns and performed with every 
well child visit thereafter.  
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Vision screenings in the very young can be difficult to perform due to unwillingness to 
cooperate and lack of verbal skills. Automated visual screeners (AVS) have been shown to be 
effective in the very young population as well as those individuals with autism, attention deficit 
hyperactivity disorder (ADHD), and other behavioral issues.  
AVS were available commercially about two decades ago. Since then AVS have 
improved and continue to become popular in pediatric clinics, family practice clinics, as well as 
schools for vision screenings. Studies continue to demonstrate the validity of AVS and are 
approved by the AAP in use of preschool age children. AVS are quick and easy to use within a 
pediatric clinic and can easily be incorporated into a well-child check without adding much time 
(Donahue et al., 2013; Peterseim et al., 2015).  
When screening and treating for visual disorders at this early age, especially refractive 
disorders, partial to full blindness can be prevented and barriers to literacy, social-emotional 
development, self-esteem, and higher academics can be eliminated (AAP, AAPOS, 2003; 
Halegoua, 2015; Yan et al., 2015). 
Statement of the Problem 
This evidence-based practice project was to address vision screening among a 
preschool population in a pediatric clinic to detect and mitigate long term effects of amblyopic 
risk factors. Sources revealed early detection, especially in the preschool years, of vision 
abnormalities can result in full recovery of vision and decrease developmental abnormalities of 
binocular vision. Early detection may also decrease costs due to decreased medical visits and 
treatments. The AAP, AAPOS, American Academy of Ophthalmology (AAO) and American 
Association of Certified Orthoptists (AACO) (2003), report children should have a full visual 
assessment at the newborn stage and at all subsequent well child examinations following. The 
AAP, AAPOS, AAO and AACO (2003) reported in a policy statement, that early detection of 
visual abnormalities is vital to help prevent blindness, identify serious disease (including 
neurologic disorders) and prevent school performance problems in the future. 
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In children, visual impairment can delay learning causing children to be inadequately 
prepared to start preschool or kindergarten. It can also reduce quality of life and function due to 
blurring of vision. If visual problems are not detected prior to preschool, visual pathways do not 
develop properly and irreversible vision loss occurs. Physiological changes within the eye not 
only affects learning but can also have long term effects on an individual’s socialization ability 
and self-esteem as early childhood is an important time of social and functional development 
(AAP, AACO, AAPOS, AAO, 2003; Bradfield, 2013; Forcina et al., 2017; Koning et al., 2013).  
Preschool is the age group in greatest need of screening for refractive errors (Bradfield, 
2013; Forcina et al., 2017; Koning, et al., 2013). However, this age group can be the most 
difficult to screen due to inability to read visual acuity charts, identify picture charts, and lack of 
cooperation while being thoroughly examined for refractive disorders. AVS such as the 
PlusOptix™ series photoscreeners can quickly scan patients’ eyes and measure binocular 
refractive abnormalities, pupil size, ocular alignment and interpupilary distance without using 
pupil dilatation or cycloplegia (Terveen, Moser, & Spencer, 2015). 
AVS have been shown in many studies to provide practical, fast, and easy vision 
screenings. They are easy to use, portable, and provide quick and accurate detection of visual 
issues, which can be addressed by the primary care provider (PCP) or referred to pediatric 
ophthalmology for further evaluation and treatment. Studies have shown PlusOptix™ 
photoscreeners to have sensitivity as high as 94.79% and specificity up to 99% depending on 
which amblyopic risk factors are being identified (Arnold & Armitage, 2014; Chang et al., 2015; 
Singman et al., 2013; Yan et al., 2015). Sensitivity is the ability of the AVS to correctly identify 
children with amblyopia or refractive vision disorders and specificity is the ability of the AVS to 
correctly identify children without vision abnormalities (Koning et. at., 2013). Arnold and 
Armitage (2014) reported the PlusOptix™ series as having sensitivity of 83% and Specificity of 
88%. Yan et al. (2015) reported the PlusOptix’s™ sensitivity of 80.6% and specificity of 76.3% 
for amblyopia.   
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The PlusOptix™ photoscreener is designed to screen for amblyopia risk factors, 
refractive error, anisocoria (unequal pupil size), myopia, hyperopia, astigmatism, retinal 
abnormalities, and strabismus (eyes are unparalleled) in children starting at age six months 
(Chang et al., 2015; PlusOptix, 2017). Vision screening can be performed in any child, including 
those with developmental delays and attention disorders, as the only required compliance is a 
short fixation on the camera. Fixation on the camera is provoked by a “warble” sound, which 
grabs the attention of the child. The PlusOptix™ has been shown in studies to be accurate. It 
screens both eyes simultaneously, accommodating the short attention of the child. It measures 
pupil sizes and corneal reflexes automatically, compares refraction of both eyes simultaneously, 
checks corneal irregularities, checks farsightedness and nearsightedness, and checks 
symmetry of eye alignment all within a few seconds. The PlusOptix™ stores data allowing the 
provider to review information in chronological order or it can be downloaded to the patient’s 
electronic health record (EHR) and then becomes a permanent part of the patient’s chart. A 
print out can be made from the vision screener as well and given to parents to take with them 
(Bradfield, 2013; Peterseim et al., 2015; Terveen, Moser, & Spencer, 2015; PlusOptix, 2017; 
Yan et al., 2015; Yilmaz et al. 2015). 
Data from the Literature Supporting Need for the Project 
The USPSTF (2011) reported “1 to 5 percent of U.S. preschool aged children have some 
sort of visual impairment”. The USPSTF also reported on a population based study in Los 
Angeles county California of over 6,000 children; amblyopia was present in 2.6 percent of 
Hispanic/Latino children and 1.5 percent black children (USPSTF, 2011). The USPSTF did not 
list the age group of these 6,000 children or specific ethnicity. A Cochrane database systematic 
review reported the prevalence of amblyopia between 2 and 5 percent in preschool aged 
children (Powell & Hatt, 2009). 
USPSTF reported finding adequate evidence to report early detection and treatment of 
amblyopia and amblyopic risk factors between ages 3 and 5 leads to “improved vision 
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outcomes” (USPSTF, 2011, p. 222). USPSTF also concluded “with moderate certainty that 
vision screening for children three to five years of age has a moderate net benefit” (USPSTF, 
2011, 222).  
Bradfield (2013) reported on a meta-analysis of four randomised clinical trials which 
evaluated the treatment effect on children based on age of amblyopia treatment. The meta-
analysis concluded children treated prior to seven years old, between ages 3 and 7, were more 
responsive to treatment compared to those treated after age seven.  
A Cochrane database systematic review done by Powell and Hatt (2009) reports no 
evidence of randomised controlled trials looking at the impact of early vision screening, 
detection, and treatment of amblyopia. Another aspect of Powell and Hatt’s review was to report 
evidence of disabilities in those living with uncorrected amblyopia. The evidence cited was 
observational studies from children screened. Powell and Hatt concluded there was not enough 
evidence from good quality trials at the time to show optimal protocols for vision screening 
Studies are starting to surface looking at the effectiveness of AVS at detecting visual 
abnormalities in the preschool age. Studies report the effectiveness of screeners by determining 
their sensitivity, specificity, (defined previously) and positive predictive value. Positive predictive 
value (PPV) is the true positive measure of a diagnostic test, which describes the test function 
(Gordis, 2014). PPV helps answer the question of what proportion of individuals that test 
positive actually are positive for a disorder or disease (Gordis, 2014).  Singman, Matta, 
Fairward, and Silbert (2013), reported the PlusOptix™ photoscreener having a sensitivity of 
88%, specificity of 87% and a predictive value of 94% in an age group of < 1 year of age to 15 
years. Mu et al. (2016) reported the PlusOptix™ photoscreener as having great promise with 
sensitivity of 94.79% and specificity of 85% for detection of amblyopia risk factors in a 
population of 4 to 7-year old. Arnold and Armitage (2014) reported in their comparative analysis 
of four different photoscreeners, the PulseOptix™ screener had 80%-83% sensitivity, and a 
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specificity of 85% to 88% with a positive predictive value of 87% in a population of 1 to 12-year 
old  
The American Academy of Pediatrics issued a news report in December 2015 
condoning instrument-based screening as a valid method of screening in very young children 
(AAP, 2016). The AAP also reported AVS can detect visual impairments most commonly found 
in young children, such as amblyopia, high refractive error, and strabismus (AAP, 2015). 
Data from the Clinical Agency Supporting Need for the Project 
The facility where the doctor of nursing practice (DNP) project took place was in a large 
Midwest community which opened its doors in 1977 to provide clinical and research programs 
focusing on childhood disorders such as deafness, and visual impairment. The hospital now 
offers a broad range of clinical services including: general pediatric care; inpatient hospital; 
surgery center; ear, nose and throat service; orthopaedic; internal medicine; pediatric 
gastroenterology; allergy and asthma; pediatric pulmonology; behavioral health; audiological 
and ophthalmologic care. The hospital and clinics have kept to their original mission of providing 
healing and hope to children and their families with physical and mental illnesses. The hospital 
strives to assemble nationally known personnel in research and clinical treatment to provide 
state of the art continuum of care 
(https://www.boystownhospital.org/AboutUs/aboutUs/Pages/Mission.aspx). 
In keeping with the mission, the pediatric clinics aim was to implement earlier visual 
screenings in their six general pediatric clinics with the PlusOptix™. By implementing AVS in 
each of the six general pediatric clinics, providers were able to obtain more accurate visual 
screenings with early detection of visual abnormalities. Providers could then refer patients to 
specialists on site as needed for continuity of care.  
The pediatric clinics abide by state law in providing comprehensive vision screenings 
using the Snellen eye chart and physician eye exam at pre-kindergarten and seventh grade 
physicals (Nebraska State Legislature 79, 2013). Visual screenings using the Snellen chart 
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were not typically done at other well-child check-ups (WCC) due to patient load, time 
constraints, and unwillingness of preschool age children. Provider visual exams were being 
done at WCC. However, visual checks with the naked eye cannot pick up all the many different 
visual abnormalities without the use of cycloplegia retinoscopy (pupil dilatation). By 
implementing use of PlusOptix™ visual screeners, providers were able to perform regular visual 
screenings starting at age 9 months, 24 months, 36 months, and 48 months which have been 
shown in literature to be of importance for visual screenings.  
Purpose of the Evidence-Based Practice Project 
Sources show early detection, prior to starting preschool or kindergarten, of visual 
abnormalities is of vital importance for early and maximal treatment. This evidence-based 
practice (EBP) project was implemented within a general pediatric clinic which serves a wide 
range of socioeconomic and ethnic populations in a large Midwest community. The purpose was 
to implement automated visual screenings at well-child visits for ages 9 months, 24 months, 36 
months, and 48 months to check for amblyopia risk factors and visual abnormalities. Screening 
for these age groups prior to the PlusOptix™ were done by the providers visual exam of the 
eye. No Snellen Chart testing was done on a regular basis for these age groups.   
Compelling Clinical Question/PICOT Question 
Would screening pediatric patients within this general pediatric clinic result in early 
findings of amblyopia and amblyopia risk factors? This led to the PICOT question: In a pediatric 
population aged 9 months, 24 months, 36 months, and 48 months (P), how does early vision 
screening using automated photo vision screeners (I) compared to traditional vision screening 
techniques (C) affect the number of refractive errors detected (O) within three months (T)? 
Significance of the EBP Project 
The ultimate goal of this EBP was to compare vision screening results from traditional 
provider screening methods to screening results from an AVS, the PlusOptix. This would 
compare referral rates between the two groups. Failed screening results from the pre- and post-
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implementation groups would be compared to follow-up ophthalmology results to check for 
sensitivity and specificity of screening methods provided during WCC. By implementing and 
gathering data on AVS outcomes within these pediatric clinics, the clinics could show sensitivity 
and specificity of the PlusOptix, the necessity of having this type of screening tool in each clinic, 
and continued need for early vision screenings prior to kindergarten. Collection and aggregation 
of data on screenings and referrals benefits individual patients within the clinics as well as the 
broader population served in the community by advancing the understanding of early vision 
screenings, visual disorders, and treatment. 
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CHAPTER 2 
THEORETICAL FRAMEWORK, EBP MODEL, AND REVIEW OF LITERATURE 
In this chapter, an overview of the theoretical framework and EBP model chosen to 
guide the DNP project are provided, along with their application, strengths, and limitations. 
Sources of relevant evidence are revealed with the hierarchy levels and appraisal information. 
Synthesis of critically appraised literature, best practice model recommendation, and how the 
best practice model answered the clinical question are discussed.  
Theoretical Framework 
Overview of Theoretical Framework 
Health Promotion Model (HPM) by Nola J. Pender was used as the theoretical 
framework to help guide the EBP project. Pender’s HPM was originally published in 1982, it was 
revised in 2001 into the Pender Health Promotion Model by Pender, Murdaugh, and Parsons 
(George, 2011). The HPM complements other health protection models to enhance health and 
well-being. It offers a process to help motivate individuals to participate in positive behaviors to 
enhance their health. Pender’s HPM stresses the importance of self-direction, self-regulation, 
and perceptions of self-efficacy (George, 2011). The HPM operates from four main 
assumptions: Individuals seek to regulate their own behavior; individuals interact with the 
environment, transforming themselves and the environment; health providers make up part of 
an individuals’ interpersonal environment, which will influence the individual throughout the 
lifespan; and self-initiated rearrangement of the person-environment is necessary for behavior 
patterns to change.   
There are eight theoretical propositions or behaviors within the HPM believed to be 
major motivators in individual health-promotion and include: perceived benefits of action, 
perceived barriers to action, perceived self-efficacy, activity-related affect, interpersonal 
influences, situational influences, commitment to a plan of action, and immediate competing 
demands and preferences (Friedman, Bowden, & Jones, 2003; George, 2011). Perceived 
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benefits of action come from an individuals’ personal experience either from being directly 
involved or observation of a family member or friend. Perceived barriers to action are just that 
“perceived” but can have a major impact on decision making. Perceived self-efficacy is related 
to one’s own judgement about self, individual skills, and whether an individual can accomplish 
the desired behavior. Activity-related affect is the result that a particular behavior or action had 
on an individual. The activity-related affect considers the affect before, during, and after the 
action. The more positive the subjective feeling has on an individual the greater the feelings of 
efficacy. These greater feelings of efficacy can lead to positive affect. Interpersonal influences 
are the individual’s own thoughts or beliefs, which may or may not accurately describe a 
behavior or situation, and can be influenced by family, friends, or other outside sources.  
Situational influences affect a behavior in different situations based on a person’s perceptions of 
options available or demanding characteristics of the environment such as: hand washing 
requirements in a work place or dress code requirements. Situational behaviors require the 
individual to participate in a way they may not normally. Commitment to a plan of action 
identifies a strategy for reinforcing or carrying out a behavior which then leads to implementation 
of the behavior. Immediate competing demands and preferences refer to alternative behaviors 
where the individual has little control such as work or family commitments, whereas competing 
preferences are alternative behaviors where the individual has high control such as choosing to 
eat ice cream.  
The HPM postulates that specific behaviors and cognitions are directly related to 
individual health promotion behaviors (Friedman, Bowden, & Jones, 2003; George, 2011). An 
individual’s prior behavior as well as inherited and acquired characteristics have great impact on 
the individual’s beliefs, affect, and how the individual views health promoting behaviors. An 
individual is more likely to engage in behaviors where valued beliefs are enhanced. When an 
individual has positive perceptions, believes there are minimal barriers to the action, has 
positive feelings about the health behavior, has positive family and peer support, has positive 
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role models and available environmental resources the individual tends to commit to a plan of 
action. This in turn promotes positive health behavior. The intent of the health promotion plan is 
that the individual will realize positive benefits to their health and well-being. The benefits 
realized would not just be for the present but benefits which will lead to overall health to last 
them a lifetime and be passed down to generations to come (Friedman, Bowden, & Jones, 
2003; George, 2011).  
Application of Theoretical Framework to EBP Project 
Pender’s HPM focuses on individual characteristics, experiences, behavior-specific 
cognitions, and one’s affect and behavioral outcomes. The HPM was appropriate for this EBP 
project as the clinic location for the project prides itself on health promotion and disease 
prevention. Pediatric providers highly recommend routine yearly health maintenance checks 
until patients reach 19 years of age or 23 years of age (when they are finished with college). 
Well-child checks are gently reinforced by requiring patients to be listed as a new patient if they 
have not been seen within the clinic setting by their PCP for two years or longer. Appropriate 
appointment times can then be set to allow enough time for a thorough exam to make sure the 
individual is healthy and their chart is accurately updated. By requiring individuals to maintain 
yearly well-checks, providers are able to catch health issues before they become a major 
problem and possibly preventing health problems. Yearly well-checks also allow providers to 
stay abreast of chronic health conditions so when there is an acute illness, proper care can be 
taken to insure a quick and uncomplicated recovery. The goal of requiring regular exams is to 
model and promote positive health behaviors which will influence individuals to commit to for a 
lifetime.  
 New implementation of AVS was one-way the providers could continue to promote 
health and disease prevention within their general pediatric clinics. By using the latest 
technology of AVS, providers were able to screen at earlier ages for visual errors as well as 
provide a more in-depth screening at well-child checks (WCC). Many studies have shown early 
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detection, prior to starting preschool or kindergarten, of visual abnormalities is of vital 
importance for early and maximal treatment. Visual abnormalities reduce quality of life and 
function due to blurring of vision. If visual problems are not detected prior to preschool, visual 
pathways do not develop properly and irreversible vision loss occurs (AAP, AACO, AAPOS, 
AAO, 2003; AAP, 2016; Bradfield, 2013; Donahue et al., 2013; Terveen, Moser, & Spencer, 
2015). The USPSTF reported “1 to 5 percent of U.S. preschool aged children have some sort of 
visual impairment” (USPSTF, 2011, p. 2) and Mu et al. (2016), estimate 1.6% to 3.6% of 
children in industrialized nations have a preventable visual impairment. Koning et al. (2013) 
found in a 7-year cohort of 4624 children with an overall prevalence of amblyopia to be 3.6%.  
 Pender’s HPM suggests if a family perceives a threat and there are opportunities for 
decreasing that threat, such as health screenings, the family will be more likely to act on it 
(Friedman, Bowden, & Jones, 2003). By using AVS within the clinic setting during routine WCC, 
providers could perform in depth vision screenings to detect problems, a screening the patient 
might not have received otherwise. This Midwest hospital and clinics serve a wide 
socioeconomic and ethnic population with the majority of them having little to no insurance. 
Therefore, many of the patient population does not seek out preventive eye care from an 
optometrist or ophthalmologist. The HPM was used to help modify patient behaviors by looking 
at modifying factors (demographic variables, sociopsychological variables, structural variables) 
to show perceived threats and provide cues to action.  
The six major motivators were taken into consideration when using the HPM as a guide 
for educating parents and patients for the need of early vision screening. Education was 
provided prior to performing AVS screenings from evidence found in the literature which shows 
benefits of action (early vision screening). When providing information, parents and patients will 
be able to actively own the behavior of early vision screening. Perceived barriers to action, such 
as little or no insurance, were addressed by assuring families most insurance companies cover 
vision screenings using AVS. Clients were not charged for the screening using the PlusOptix™ 
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if insurance did not cover it or cover all the cost. Early vision screenings can reduce treatment 
length and overall cost, further addressing perceived barriers to screening. This further 
influences the six behavioral motivators affecting optimal well-being, personal fulfillment, and 
productive living.   
Strengths and Limitations of Theoretical Framework for EBP Project 
Health promotion and disease prevention should be the primary focus in the health care 
setting and needs to be easy to understand in order to change or reinforce positive health 
behaviors. The HPM allows for ease of applicability by its simplistic stepwise approach. Its’ 
holistic focus based in nursing gives it strength by promoting independent practice which 
provides health promoting interventions and education to individuals. The HPM can be used by 
other disciplines even though it was proposed as a framework for nursing. The HPM was 
intended for any individual in any situation other than the illness state. By using the eight 
theoretical propositions or variables the model allows for a complete picture of the patient and 
progression toward improving health behaviors. However, the many variables within the HPM 
also can be a limitation making it difficult to test all of the relationship statements. Without being 
able to test all the theoretical propositions or variables at once, one is not able to see how the 
variables influence each other or the outcomes of health promotion. Not only is testing all the 
variables difficult to do, it may also be difficult for providers to implement all eight variables 
within a reasonable time-frame. George (2011) points out another limitation within the HPM. The 
spiritual growth component is not considered under personal factors of the HPM. Spiritual 
growth is a component often listed and helps in guiding an individual when using other 
theoretical models.    
Evidence-based Practice Model 
Overview of EBP Model 
The term “evidence-based practice” (EBP) derives from the definition of “evidence-based 
medicine” (EBM) and is defined as: “Evidence based nursing practice is the conscientious, 
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explicit, and judicious use of theory-derived, research-based information in making decisions 
about care delivery to individuals or groups of patients and in consideration of individual needs 
and preferences” (Ingersoll, 2000, p. 152). 
The Stetler Model (SM) provides a stepwise process for gathering sound evidence that 
can guide safe and effective care or evidence-based practice. The SM uses a prescriptive 
approach emphasizing critical thinking as a key role. The SM relies on five steps which include: 
preparation, validation, comparative evaluation/decision making, translation/application, and 
evaluation (Stetler, 2001).  
Preparation entails identifying a need, identifying the environment it involves, organizing, 
and initiating evidence research. The SM advises nurses or providers to be very clear during the 
preparation phase by emphasizing clarity of purpose along with potential significance of internal 
or external factors (organizational goals, imposed deadlines or politics involved with making a 
change, etc.). Clarity includes specifics regarding who the stakeholders are, what types of 
research or information will be needed to show the need for change, and how the outcomes will 
be defined (Ciliska et al., 2011; Stetler, 2001; Young, 2012). 
Validation requires combing through a body of evidence to select evidence which best 
identifies the need for change. In this second phase of the Stetler model, APN’s and nurses 
decide if there is enough credible evidence to support the wanted or needed change to continue 
moving forward with the process. The process is done by utilization focused critique and 
synopsis (Ciliska et al., 2011; Stetler, 2001; Young, 2012). 
Comparative evaluation/decision making involves applying a set of criteria to evidence 
collected in the validation phase to further decide what evidence best identifies or supports the 
practice change. Comparative evaluation/decision making is where organization of collected 
evidence and critical appraisal of evidence collected takes place. Evidence is either labeled not 
to use, to use, or to consider use (still being considered until additional information or internal 
evidence is gathered) based on strength of the evidence once the critical appraisal is done. 
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Final decisions are then made as to whether enough research exists to support the practice 
change (Ciliska et al., 2011; Stetler, 2001; Young 2012). 
Translation/application requires converting the evidence findings into practice by 
disseminating the evidence to those involved and needed in the application process. Then a 
plan is put into action. Translating or applying the plan is not always an easy process depending 
on the type of change to be made and who is involved. Getting everyone on board is often 
difficult. Providers need to carefully consider how information will be distributed to all involved 
parties. Young (2012), purports “change is the heart of this phase” (p. 390).  
Evaluation then involves assessing the new plan of practice to ensure goals were met, 
monitor for any adverse occurrences, if any changes need to be made, and how to continue 
providing the new plan of practice (Ciliska et al., 2011; Young, 2012). In the evaluation process 
and decisions are made if the new process or clinical practice change can be extended into 
other clinic areas. The evaluation process is also a continuous process of internal data 
collection, feedback from the users of the clinical practice change in order to obtain continual 
improvements.  
Application of EBP Model to EBP Project 
Previous screening practices at the project site included detailed vision screenings using 
the Snellen chart at ages 4 and 5 years prior to beginning kindergarten. Even then, screenings 
did not include comprehensive refractive error screenings that typically involve pupil dilatation 
known as cycloplegic screening. As mentioned previously in this paper, early visual screenings 
for refractive errors is crucial within the early years of life. The project site providers see patients 
across a wide range of socioeconomic and ethnic backgrounds, many with little to no insurance 
coverage. That being said, many will not see an optometrist or ophthalmologist for preventive 
visual screenings. It was hoped that the AVS would provide needed refractive error screenings 
to the project site pediatric population.  
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Using the (SM), evidence was collected and aimed to show the use of AVS are effective 
at screening for refractive visual errors as early as age nine months, as recommended by the 
AAP and USPSTF (The American Academy of Pediatrics [AAP], 2015; AAP, 2016; Forcina et 
al., 2017; Koning et al., 2013). The American Academy of Pediatrics issued a news report in 
December 2015 stating instrument-based screening is a valid method of screening in the very 
young children (AAP, 2015; AAP, 2016). The AAP and USPSTF also reported endorsing AVS 
as they can detect amblyopia and ocular conditions known to cause amblyopia such as high 
refractive errors and strabismus. (AAP, 2015; AAP, 2016). After carefully weighing available 
research, the project manager believed there was significant evidence to proceed with the EBP 
project.  
Careful condensing, organizing, and labeling of evidence gathered during the evidence 
phase was done by applying the Critical Appraisal Skills Programme (CASP) tool. After careful 
consideration, CASP was decided upon for its reliability, completeness, and its ease of use. 
CASP includes a set of eight appraisal tools to evaluate systematic reviews, randomised 
controlled trials, cohort studies, case control studies, economic evaluations, diagnostic studies, 
qualitative studies and clinical prediction rule (http://www.casp-uk.net/casp-tools-checklists). 
Melnyk and Fineout-Overholt’s (2011) Rapid critical appraisal checklist was used to carefully 
evaluate the clinical guidelines found while collecting evidence. Enough sound evidence was 
collected to move onto the fourth phase of the SM. 
Evidence was communicated to all providers and staff who were involved in carrying out 
the change in practice through copies of research information collected, power points and 
videos provided from PlusOptix™. PlusOptix™ screeners were put in the budget plan in hopes 
the clinics would purchase some of the screeners to be tried out within the general pediatric 
clinics. Based on evidence provided and one of the clinics provider having previous experience 
with using this type of visual screener, budget was approved for purchase of six screeners. One 
screener was placed in each of the six general pediatric clinics. Education was provided to each 
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provider and clinic staff member who were involved in using the screeners. Education included 
information on the devices themselves, as well as policy and procedure for using the 
PlusOptix™ within the clinic setting.  
Phase five of the Stetler model evaluated expected outcomes stemming from the original 
PICOT question: In a pediatric population aged 9 months, 24 months, 36 months, and 48 
months, how does early vision screening using automated vision screeners compared to 
traditional vision screening techniques affect the number of refractive errors detected within 
three months? 
Strengths and Limitations of EBP Model for EBP Project 
The Stetler Model has a great use within individual practice, emphasizing critical thinking 
and decision making. Its five phase step approach aids in the critical thinking and decision-
making process with ease of use. It allows for synthesis of internal and external evidence in 
routine practice which fits well within the general pediatric clinic settings. The systematic 
approach aids in critiquing and translation of research findings into clinical practice. By using the 
systematic approach of the SM, evidence is substantiated to support the needed clinical change 
within the project setting.   
The SM is not set up for ease of use as an overall organizational change process but 
more for an individual clinic practice change agent. Ciliska et al. (2011) reports overall 
organizational change is not as easy application for the SM due to its practitioner focus for 
clinical change. The SM guides practitioners in a five-phase approach and how the practitioner 
can implement research findings to direct patient care.  
Literature Search 
Sources Examined for Relevant Evidence 
An extensive literature search for relevant and best evidence was conducted using 
multiple databases including Cumulative Index of Nursing and Allied Health Literature 
(CINAHL), ProQuest Nursing and Allied Health, Johanna Briggs Institute EBP Database, The 
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Cochrane Library, Medline with full text, and National Guideline Clearinghouse. A hand search 
was also conducted from relevant articles’ references and reviewed for applicability to the EBP 
project.  
Key words from the PICOT question were used for search terms. A combination of 
search terms were tested during this evidence search yielding no results. After combining key 
words, implementing Boolean phrases, playing with date limiters, employing the use of 
quotations and asterisks a “best search” was reached. The final set of keywords/terms settled 
on and yielding the best results in all six databases were: PlusOptix™, Amblyopia, refractive 
error, vision screen, and photoscreen (see Table 2.1).   
The “best search” yielded 429 relevant sources. Forty-nine were chosen by the project 
leader after reading through the summaries for literature review. From the 49, seven were kept 
by the project leader based on relevance to the EBP project, evidence level, and inclusion 
criteria. Inclusion criteria were the years between 2007 and 2017 and English language for 
literature review.  
CINAHL yielded 70 sources with four kept for best evidence. ProQuest Nursing and 
Allied Health yielded 146 sources using the key terms. The three sources kept from ProQuest 
overlapped with Medline and CINAHL. Johanna Briggs Institute yielded eight sources with no 
sources kept for best evidence. The Cochrane Library yielded 33 total sources using keywords, 
with two sources kept for best evidence. Medline with full text using the final set of search terms 
yielded the most sources at 172 for best evidence. Seven sources were kept from Medline. 
Three of the sources overlapped with CINAHL and three sources overlapped with ProQuest. No 
articles were kept through the hand search process for best evidence.  
Articles included in final results pertained to pediatric population ages birth to 5 years, 
male and female, need for early vision screening, automated vision screener comparisons to 
each other and to traditional cycloplegia retinoscopy, and early screening methods. Final results 
included after searching databases listed, key words/terms, inclusion criteria and hand 
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searching; ten sources were kept for best evidence including 2 guideline summaries. Ten 
sources (including text books) and three guideline summaries were kept for use as background 
knowledge in this EBP project.  
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Table 2.1 
Literature Search Results 
 
Database 
 
 
Keyword(s) 
 
Limiters 
 
Date 
Limiters 
 
 
Results 
 
Relevance/Kept 
 
CINAHL 
PlusOptix OR Amblyopia OR 
"refractive error*" AND “vision 
screen*” OR photoscreen* English language 
 
 
2007-2017 
 
70 
 
 
 
 
4 (3 overlap with 
Medline; 1 overlaps 
with ProQuest) 
 
 
  
 
ProQuest 
Nursing and 
Allied Health 
PlusOptix OR Amblyopia OR 
"refractive error*" AND “vision 
screen*” OR photoscreen* 
 
 
English language 
 
 
 
2007-2017 
146 
 
 
 
3 (2 overlap with 
Medline; 1 overlaps 
with CINAHL) 
 
 
Johanna Briggs 
Institute 
PlusOptix OR Amblyopia OR 
"refractive error*" AND “vision 
screen*” OR photoscreen* 
English language 
 
 
2007-2017 8 
 
 
0 
 
 
Cochrane 
PlusOptix OR Amblyopia OR 
"refractive error*" AND “vision 
screen*” OR photoscreen* 
English language 
 
 
2007-2017 33 
 
2 (1 from Cochrane 
review; 1 from trials) 
 
Medline with 
Full text 
PlusOptix OR Amblyopia OR 
"refractive error*" AND “vision 
screen*” OR photoscreen* 
English Language, Word in major 
subject heading (MJ) 
 
 
2007-2017  
172 
 
7 (3 overlap from 
CINAHL; 3 overlaps 
with ProQuest) 
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Levels of Evidence 
Critical appraisal of evidence is necessary to obtain evidence that is valid, reliable, and 
applicable to support the clinical change. In order to critically appraise evidence, sources must 
be ranked on a hierarchy scale. Sources of evidence for this EBP project were evaluated and 
categorized using the “Hierarchy of Evidence for Intervention/Treatment Questions” also known 
as “Pyramid of Evidence” (Melnyk & Fineout-Overholt, 2011; Russel, 2012) (see Table 2.2). A 
total of seven sources were kept and ranked using the Pyramid of Evidence. Hierarchy of 
evidence is a rating scale used to grade evidence pertaining to the topic at hand in order to 
guide the investigator to the most reliable information. There are seven essential levels to the 
pyramid of evidence, Melnyk and Fineout-Overholt mentions (2011). The highest of the rankings 
start at the top of the pyramid as Level I and moves down towards Level VII. Level I include 
systematic reviews and meta-analysis of all relevant randomised controlled trial. These are 
considered the best evidence for guiding practice. Level II is evidence obtained from well-
designed randomised controlled trials. Level III evidence is obtained from well-designed non-
randomised controlled trials. Level IV is evidence from case-control and cohort studies. Level V 
includes systematic reviews or descriptive and qualitative studies. Level VI are sources of 
evidence from single descriptive or qualitative studies. Level VII consists of evidence from 
authoritative opinions and/or reports from expert committees such as guidelines from USPSTF 
or AAP (Melnyk & Fineout-Overholt, 2011; Russel, 2012). By placing the available research or 
information gathered into a hierarchy pyramid, as Melnyk and Fineout-Overholt recommends, it 
allows for clarity in evaluation of the evidence as it pertains to the PICOT question being asked.  
The CASP tool was used to test the strength of the evidence for validity, importance of 
results of the evidence, and if the results of the evidence are useful (http://www.casp-
uk.net/checklists). CASP provides a set of eight questionnaires to be used when reading 
research to help grade each level of evidence for strength, results, and usefulness. Once the 
evidence has been found valid, clinical significance of the results needs to be determined 
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looking at confidence intervals, p values, and sensitivity analysis. Evidence is then given an 
appraisal rating based on quality of the study performed. CASP does not provide this rating 
scale with its questionnaires for each type of study. It is up to the clinician to apply a rating 
scale. Appraisal rankings in this EBP project were labeled: high, medium, and low. If clinical 
significance is found, then determination needs to be made how the evidence applies to the 
individual clinical practice change. Critical appraisal of evidence helps provide transparency to 
the evidence found and helps examine sources for bias.  
There are four main types of biases: selection, detection, attrition, and performance. 
Selection bias is controlled by randomization, concealment of population, treatments, and 
results. Detection bias is controlled by researchers and all participants involved, including data 
collectors and population participants being masked to outcomes, and grouping of participants. 
Attrition bias looks at how participants lost to fall out are accounted for. Performance bias is 
controlled by masking of participants and researchers to group allocation (Powell & Hatt, 2009). 
Appraisal of Relevant Evidence 
Level I Evidence 
A systematic review by Powell and Hatt (2009) was retrieved from the Cochrane 
Database of Systematic Reviews. The purpose of the review was to look at randomised 
controlled trials and cluster-randomised trials to evaluate vision screening and its results on 
amblyopia compared to non-screened pediatric population. Powell and Hatt (2009) assessed 
study summaries independently then obtained relevant full text articles. However, they 
discovered there were no studies on screened versus unscreened children to review. The 
studies were all observational.  
One-thousand forty-nine sources were obtained, three sources were kept for the 
systematic review. Powell and Hatt (2009) found that despite the large amount of literature 
available regarding pediatric vision screenings, they were not able to find research trials 
designed to compare prevalence of amblyopia in screened versus non-screened children. They 
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concluded there is no optimal protocol for carrying out screening and there is a clear need for 
more reliable research on the effectiveness of vision screening programs. Powell and Hatt 
suggested the impact of screening for amblyopia is to detect other vision abnormalities such as 
refractive errors. Recommendations were made for more evidence regarding living with 
uncorrected amblyopia. Appraisal quality given to this systematic review is high as the review 
clearly addressed the focused questions, best studies were used, three databases were used to 
find sources relevant to focused question, and rigor was used to assess quality of studies found. 
Overall results were clear; however, specific statistics were not indicated with confidence 
intervals, odds ratio, or other statistical data.   
The Oregon Evidence-based Practice Center (EPC) conducted a systematic review of 
randomised trials and controlled observational studies searching from 1950 to July 2009 
(Oregon Evidence-based Practice Center [EPC], 2011). The EPC looked to answer eight key 
questions:   
 Is vision screening in children ages 1-5 years associated with improved health 
outcomes?  
 Does effectiveness of vision screening in children ages 1-5 years vary in different 
age groups?  
 What is the accuracy and reliability of risk factor assessment for identifying 
children ages 1-5 years at increased risk for vision impairment?  
 What is the accuracy of screening tests for vision impairment in children ages 1-5 
years?  
 Does accuracy of screening tests for vision impairment vary in different age 
groups in children ages 1-5 years?  
 What are the harms of vision screening in children ages 1-5 years?  
 What is the effectiveness of treatment for vision impairment in children ages 1-5 
years?  
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 What are the harms of treatment in children ages 1-5 years at increased risk for 
vision impairment or vision disorder? (Oregon Evidence-based Practice Center 
[EPC], 2011).  
To answer question one, the EPC could not find randomised trials evaluating outcomes 
of vision screenings in children ages 1-5 years compared to children without having vision 
screenings.  However, the EPC did find a large randomised trial, felt to be of fair quality, nested 
within a population-based cohort study. The randomised trial showed decreased likelihood of 
amblyopia at age 7.5 years after having repeated orthoptists screenings between ages 8 
months to 37 months. No randomised trials were found comparing outcomes of preschool vision 
screening in different age groups to answer question 1a. No difference between vision 
screenings were reported in one of the cohort studies looking at vision screenings at ages 2 and 
4 years compared to screenings prior to age 2 years. The EPC found no studies evaluating the 
accuracy or reliability to identify children at higher risk based on demographic or clinical 
features, answering question 2. 
Question three by the EPC revealed thirty-one studies looking at the accuracy of various 
preschool vision screening tests compared to standard cycloplegic refraction screening. None of 
the studies were recorded as being “good-quality”. Overall conclusion by the EPC was all 
screening tests showed accuracy estimates suggesting usefulness for identifying children ages 
1-5 years at higher risk for amblyopic risk factors.  
Question four was difficult for the EPC to answer as evidence related to comparing 
accuracy of screening tests for vision impairment in different age groups from ages 1 year to 5 
years was limited. Four of the studies reviewed found no difference among the various age 
groups. Four studies found lower testability using certain screening methods in ages 1 year to 3 
years compared to children ages 4 years to 5 years. Studies were limited on the harms of vision 
screening in children ages 1 to 5 years. A large cohort reported a fifty percent reduction in odds 
of being bullied at age 7.5 years of age in children who did receive vision screening compared 
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to those children who did not receive vision screening. No study looked at harms to 
unnecessary treatment or use of corrective lenses for amblyopia on long-term vision or 
functional outcomes.  
Question five was addressed with one good quality trial showing patching of one eye 
plus eyeglasses and eyeglasses alone were more effective than no treatment at all. Two other 
studies reviewed showed small average improvement in visual acuity in children with amblyopia 
after a five to twelve-week follow-up. No studies were found that looked at effects of treatment 
compared with no treatment on school performance.  
Five studies reviewed showed some increased risk for temporary vision loss in the non-
amblyopic eye when the amblyopic eye was treated, helping to answer question 6 of the EPC’s 
review questions. No risk was found in three trials for increased risk for visual acuity loss 
between patching and using atropine regimens for treatment.  
After attempting to answer all six questions posed by the EPC, the overall conclusion by 
the EPC was that preschool vision screenings are effective for diagnosis and treating visual 
disturbances, mainly refractive errors, compared to no early screenings in preventing long term 
problems.  Appraisal score given to this systematic review is high. The EPC clearly addressed 
all six of the focused questions, a large assortment of study trials were included. Detailed 
information was given as to the rigor of studies included with overall results of each study 
reviewed listed in the report. All important outcomes were considered including population 
setting. The EPC did report all study trials reviewed were studies done within community 
settings or ophthalmology setting and this could be a limiting factor.  
Level II Evidence 
Arnold and Armitage (2014) performed a random controlled trial on 108 children ages 1 
year to 12 years in an Alaska Pediatric eye practice. The purpose was to compare four different 
visual photoscreeners, the GoCheckKids™ (www.gocheckkids.com), PlusOptix S09™ 
(https://PlusOptix.com), SPOT™ (www.welchallyn.com), and iScreen 
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3000™(www.iScreen.com). GoCheckKids™ is software that can be uploaded to Apple products 
such as; iPhone® and iPod touch®. Images of eyes are taken then uploaded to the 
GoCheckKids™ website for interpretation. PlusOptix S09™ is an infrared photoscreener which 
has the individual fixate on a light emitting from camera. Images are taken of eyes/pupils then 
interpreted by PlusOptix™ software for refractive error, ocular alignment, and pupil size. 
SPOT™ is a hand-held photoscreener which takes images of the eyes/pupils and makes 
estimation of pupil size, interpupilary distance, ocular alignment, and refractive error. The 
SPOT™ has a WIFI remote printer so readings can be printed. iScreen™ is also a hand-held 
photoscreener which has a keyboard, monitor, and port for data import or export. iScreen™ 
operates with a red laser beam that is aimed at the eyebrows, it then captures an image of the 
pupils. Images can be sent to an iScreen™ interpretation database immediately or stored and 
uploaded some later time once multiple screenings have been completed (Arnold & Armitage, 
2014).  
 Each participate was screened with each of the four screeners in random order by 
orthoptist and pediatric ophthalmologist with results masked to the participant and the screeners 
until all screenings were completed (Arnold & Armitage, 2014). Validation statistics were 
completed using a 2X3 table to show sensitivity and specificity of each photoscreener used. 
Sensitivity of all four photoscreeners averaged 80%. Specificity of all four photoscreeners 
averaged 88%. Arnold and Armitage reported all four screeners had advantages and 
disadvantages. The PlusOptix™ was not cordless and required connection to a computer with a 
monitor by a cable; therefore, it was less portable than other screeners. It also had more 
difficulty yielding results for children with high refractive errors. However, the PlusOptix™ was 
able to report refractive error, ocular alignment, pupil size, and interpupilary distance as well as 
having good validation and calibration calculations due to revisions of prior models. iScreen’s™ 
central interpretation location leading to a longer wait time for results and refractive error was 
not estimated. iScreen™ was reported as being easy and quick to use with “excellent ABCD 
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statistics and ir-sensitivity” (Arnold & Armitage, 2014, pg. 51) the terms chosen by Arnold and 
Armitage to indicate inconclusive in the denominator of analysis (ABCD) and inconclusive 
referrals (ir-sensitivity).  
The SPOT™ took a little longer with a visual fixation time of 2 seconds or greater. 
However, the SPOT™ was reported as having “extensive eye examination” (Arnold & Armitage, 
2014) consisting of pupil size, interpupilary distance, refractive error, and an estimate of ocular 
alignment. GoCheckKids™ required steadiness by the screener in order to produce proper 
image quality.  
GoCheckKids™ had no stimulus light on the phone for the individual to fixate to assure 
proper image. Screening with the GoCheckKids™ looks at ocular alignment and red reflex 
dimensions. Images need to be uploaded for interpretation and are not readily available for 
viewing. GoCheckKids™ was applauded for its simplicity for interfacing with the iPhone®. 
Conclusion of all four photoscreeners was that all are good for accuracy of vision screening and 
valuable in identifying treatable vision disorders early enough for therapy to be successful.  
The appraisal score given to this random controlled trial was medium. The interpreter of 
the visual images was not completely blinded to patient identities. Researchers were not as 
accustomed to the GoCheckKids™ screening tool compared to the PlusOptix™, iScreen™, and 
SPOT™, as it was a newly acquired tool for them. Arnold and Armitage (2014) also reported the 
individuals screened were attending a pediatric eye clinic. Therefore, the population studied 
may not have been a good representation of the population typically seen in a general pediatric 
clinic within the community. Statistical outcomes were given but there were no in-depth 
discussions regarding statistical analysis used. Good information and sensitivities and 
specificities were provided regarding each photoscreener.  
Level III Evidence 
 Mu et al. (2016) performed a non-randomised control trial to compare visual screening 
with SPOT™ photoscreener to traditional cycloplegia retinoscopy. Children (N = 155), ages 4-7 
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years, attending a specialty eye clinic at Tianjin University hospital in Helsinki for eye check-ups 
were screened. The children were screened first with a complete ophthalmologic examination, 
then photo screening using the SPOT™ screener, followed by cycloplegia and retinoscopy. 
Optometrists were masked from results using the SPOT™ screener as well as the individual 
being screened. Measurements were unobtainable from 13 of the original 168 children due to 
fear, and others previously diagnosed with hyperopia, esotropia, congenital ptosis, congenital 
nystagmus, and congenital cataracts. Successful screening was done on 155 children, 71 girls 
and 84 boys. Twenty--six children had amblyopia, 115 had amblyopic risk factors, 65 had 
hyperopia, 28 had myopia, 59 had astigmatism, 32 had anisometropia, and 37 had strabismus. 
Wilcoxon signed rank test showed the difference between SPOT™ photoscreener and 
cycloplegic retinoscopy was not statistically significant at p < 0.01 indicating a weak correlation. 
The Bland-Altman plot test showed moderate agreement between the SPOT™ photoscreener 
and cycloplegic retinoscopy. The SPOT™ showed high sensitivity of 94.79% and specificity of 
85% in detecting amblyopia risk factors based on the AAPOS 2013 guideline. Mu et al. 
concluded the SPOT™ showed moderate agreement with the results of cycloplegia retinoscopy 
and detecting amblyopic risk factors was satisfactory but could be further improved with 
optimizing screening criteria.  
Critical appraisal score was high. The aim of the research was made clear. Ethical and 
bias issues were addressed and clearly laid out in this source. Statistical analysis was 
discussed in detail to show how sensitivity and specificity was reached. One limitation was the 
population screened had a high prevalence of amblyopia risk factors compared to community 
population or school based samples from other studies.   
 Singman et al. (2013) conducted a retrospective medical records review on an autistic 
pediatric population, ages <1 year to 15 years with the average age being 6 years, in an 
ophthalmology practice. Children (n = 4) were identified as having autism in the retrospective 
medical records review. The children were seen between January 1, 2001 and April 12, 2012.  
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Twenty-five of the forty-eight children had undilated PlusOptix™ photo screenings done with 
their clinical exam during the times listed and were chosen to be analyzed. The chosen 
population was tested two times with the PlusOptix™. The goal of the review was to compare 
reliability of the PlusOptix™ to traditional pediatric vision screenings in a pediatric population 
with autism. The PlusOptix™ does not use a flash, which can sometimes upset individuals with 
autism. It does use a chirp sound that can be turned off if the child has difficulty with noises. The 
PlusOptix™ was shown to be easy to use with rapidly available vision screening results. Results 
of double testing with the PlusOptix™ revealed 17 (68%) children had amblyopia risk factors 
with both testing’s. The PlusOptix™ was found to have a sensitivity of 88%, specificity of 87%, 
positive predictive value of 94%, and negative predictive value of 78%. Singman et al. 
concluded that it was difficult to get reliable screening results in children with autism. When 
using the PlusOptix™ providers/clinicians can obtain a quick, reliable vision screening result in 
individuals with autism and other disorders where attention span and focus is a hurdle.  
Low level critical appraisal ranking was given to Singman et al. (2013). The aim of the 
research was clearly stated and qualitative methodology was appropriate to address the aims of 
the research. Data were gathered in a way to address the research issue. However, biases, 
limitations, and ethical issues were not discussed. There was no in-depth discussion on findings 
and how it related to other studies in the literature.   
 Yan et al. (2015) performed a controlled trial without randomization to assess the 
accuracy of PlusOptix A09™ photoscreener in detecting amblyopia risk factors in children. One-
hundred-seventy-eight children ages 2 years to 14 years attending an ophthalmology clinic at 
Provincial Hospital in Shandon Helsinki were chosen for the controlled trial. Comprehensive 
ophthalmic exams were done in the following order: PlusOptix A09™ screening; orthoptic exam 
with prism alternative and cover test; anterior segment assessment using slit lamp; fundus 
exam; and then a cycloplegic retinoscopy exam. Each child was tested two times with the 
PlusOptix™. The Optometrists performing cycloplegic retinoscopy were masked to the 
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measurements obtained from the PlusOptix™. Data analysis to compare refractive 
measurements between PlusOptix™ and cycloplegic retinoscopy were calculated. Descriptive 
data were presented as mean, standard deviation, and frequency. Paired t-test and curve 
estimation regression analysis were performed to assess differences and quantitative 
relationships. The Bland-Altman plot test was used to measure agreements between the 
PlusOptix™ and retinoscopy. ROC curve was used for cut-off points. Pearson’s correlation 
coefficient was used to confirm consistency of the two measurements from the PlusOptix™.  
 Results showed 86 (48.3%) children diagnosed with amblyopia (Yan et al., 2015).  Sixty-
three (35.4%) children were diagnosed with strabismus. The PlusOptix A09™ showed 
sensitivity for detecting refractive amblyopia risk factors of 80.6%. Specificity of the PlusOptix 
A09™ for detecting amblyopia risk factors was 76.3%. After applying ROC curve, the overall 
sensitivity of the PlusOptix A09™ in detecting refractive amblyopia was 94.9% and specificity for 
detecting refractive amblyopia was 63.2%. Spherical equivalent showed significant difference 
between the PlusOptix A09™ screening results and the cycloplegic retinoscopy screening 
results with p = 0.00. Paired t-test showed p = 0.14 for mean cylinder power value (Jackson 
cross cylinder at axis 00) and p = 0.26 (Jackson cross cylinder at axis 450). The Bland-Altman 
plots showed agreement between the PlusOptix A09™ and cycloplegic retinoscopy for spherical 
equivalent and Jackson cross cylinder power values at 450 and 00. Consistency measurements 
from PlusOptix A09™ and cycloplegic retinoscopy confirmed with Pearson’s correlation 
coefficient, r = 0.95, p = 0.00.  
Conclusion by Yan et al. (2015) showed the PlusOptix A09™ is useful in large scale 
screenings for refractive errors but may not be suitable for large scale strabismus screenings. It 
does not need connection to a computer using cords which made it easily portable as well as 
providing faster data acquisition. It was also user and patient friendly. The critical appraisal 
score given to the Yan et al. study was high. Yan et al. clearly stated the aims of the research 
with appropriate methodologies applied. Recruitment strategy was clearly stated with any 
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exclusions to the study listed. The researchers clearly reported data collection and 
testing/screenings performed. There could be potential bias in this study related to the 
population chosen as it was individuals already attending an eye clinic for a check-up. This 
population may not reflect a typical cohort in a general pediatric clinic setting being seen for 
routine well child exams. Ethical issues were taken into consideration. Yan et. al discussed how 
findings were important in clinical practice and where research was still needed.  
Level IV Evidence 
 Six physicians on behalf of the American Association for Pediatric Ophthalmology and 
Strabismus organizations (AAPOS) performed a prospective population-based study review on 
a pediatric population ages 12 month to greater than 72 months (Donahue et al., 2013). The 
review was done to help develop and update guidelines to improve reporting of results and 
comparison technologies for detecting amblyopia. Updated guidelines would help propose and 
determine levels for detecting amblyopia risk factors to separate those children who are at most 
risk with those children who are not (Donahue et al. 2013). Donahue et al. reported several 
prospective population based studies to show childhood amblyopia prevalence was 
approximately 2%, same as previous reports. However, prevalence of amblyopia risk factors 
was greater than previously thought at approximately 15%-20%. These numbers showed that 
not all children with amblyopia risk factors develop amblyopia and this finding was confirmed by 
a longitudinal follow-up study. 
Findings from the reviewed studies led Donahue et al. (2013), to search for information 
to update referral guidelines to decrease “over-referrals.” Donahue et al. recommended vision 
screenings should take place at several intervals during the early developmental years instead 
of one particular time in early childhood. Findings also revealed refractive risk factor targets with 
automated preschool vision screenings. Donahue et al. concluded as technology continues to 
advance, reassessment of means for detecting amblyopia and amblyopia risk factors will need 
to take place to maintain sound screening tools.  
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Critical appraisal for these guidelines ranked as high. Donahue et al. (2013) had a valid 
development strategy which was explicit, sensible, and used an impartial process to identify and 
select evidence. The guidelines did not make explicit recommendations but rather 
recommendations that are applicable to general practice vision screenings. It was not noted if 
the guidelines had been subjected to peer review and each guideline was not tagged by 
strength of evidence in which it was linked with scientific evidence. Recommendations for use in 
the national arena of providers were clinically relevant outcomes that can be measured through 
standard care.  
 The U.S. Preventive Services Task Force (USPSTF) is one organization that helps set 
guidelines for clinical practice. In 2011, the USPSTF updated vision screening guidelines in 
children ages 1 year to 5 years. The USPSTF acknowledged 2 to 4 percent of pre-school aged 
children had amblyopia recognizing a possible cause for this as an alteration in the visual neural 
pathway in the developing brain. If amblyopia is left untreated it can lead to permanent vision 
loss. Based on review of the information, the USPSTF agreed vision screening tools, including 
AVS, have reasonable accuracy to detect visual disorders. The USPSTF also found adequate 
evidence that early detection and treatment of amblyopia improves visual outcomes with 
moderate certainty in ages 3 years to 5 years. The USPSTF discussed limited evidence on the 
harms of vision screenings.  
Final conclusions by the USPSTF (2011) for visual screening guidelines included: 
adequate evidence of early treatment of amblyopia in children younger than 3 years leads to 
improved outcomes. There was inadequate evidence for recommendations of intervals for vision 
screening. Screening and treatment later in preschool years appeared to be effective but may 
take longer to resolve thus increasing financial burden on families.  
Critical appraisal score given to the USPSTF (2011) summary guidelines was a high. 
The updated USPSTF guideline used a valid development strategy which was explicit and 
sensible. The USPSTF used an impartial process to identify and select evidence. The 
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guidelines did not make explicit recommendations but recommendations that are applicable to 
general practice of vision screenings. It was not noted if the guidelines had been subjected to 
peer review and each guideline was not tagged by strength of evidence in which it was linked 
with scientific evidence. The updated guidelines by the USPSTF provides for use in the national 
arena of providers which were/are clinically relevant listing outcomes that can be measured 
through standard care.  
Level VI Evidence 
 In a cross-sectional study, Chang et al. (2015) looked at 137 preschoolers attending six 
different preschools in O’ahu Hawai’i. Ages screened ranged from 8 months to 5 years 2 
months. Race characteristics of the preschoolers included: 48 full/part Hawaiian or Pacific 
Islander, 56 of mixed races, 21 Asian, and 12 Caucasian. The purpose of the study was to look 
at ease of use of hand-held portable vision screeners in the preschool setting. Chang et al. 
found 108 (79%) of the preschoolers passed the screening. Four were referred for astigmatism, 
four referred for hyperopia, one referred for gaze asymmetry, and two referred for 
anisometropia. Cycloplegic eye examination was not done to compare vision screening results. 
However, Chang et al. concluded the hand-held screening device has the potential to facilitate 
early vision screening in preschools in Hawaii. The AVS was quick and easy to use and also 
well tolerated by pre-school children.  
Critical appraisal score for Chang et al. (2015) cross-sectional study is low. The research 
design was appropriate for the aims of the research along with the recruitment strategy. 
However, fall out reasons were not listed or discussed. The study consisted of a small 
population size and the varied environments where screenings were done were not consistent. 
The lighting in each location was different and not taken into account when first setting up 
screening stations. Too much or too little light affects the screening results by the hand-held 
vision screener, therefore lighting is important. No in depth statistical analysis were discussed or 
sensitivity and specificity calculated due to poor referral follow-up for cycloplegic retinoscopy to 
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compare results to the hand-held screener. The cross-sectional study by Chang et al. did offer 
good information on ease of use by lay persons and tolerability of preschoolers. 
 The Lions Club of western South Dakota performed vision screenings on children ages 
six months to 12 years with the mean age being 79 months. Screenings took place in five 
different school and community center locations (Terveen, Moser, & Spencer, 2015). A total of 
4,722 children were screened with 2,373 being female and 2,349 being male. Terveen, Moser, 
and Spencer set up a quantitative descriptive design to look at data collection on the SPOT™ 
photoscreener in the South Dakota pediatric population. Data were stratified by age group with 
four different age groups: 12months -30months; 31months - 48months; 49months – 72months; 
and 73months – 144months. Data were collected on sex and percentage of children referred for 
hyperopia, myopia, astigmatism, anisocoria, anisometropia, and ocular misalignment. Sex was 
compared using chi-square test.  
Results from Terveen, Moser, and Spencer’s (2015) descriptive trial showed 563 failed 
the vision screening with the SPOT. No significant difference was noted in referrals based on 
sex (p = 0.598). Children 73 months – 144 months had the highest referral rate at 12.2%. 
Children twelve months to thirty months had the lowest referral rate at 7.9%. Reasons for 
referral included: 371 (7.9%) astigmatism; 24 (0.5%) for ocular misalignment; 101 (2.1%) 
anisometropia; 135 (2.9%) myopia; 36 (.8%) for hyperopia; 16 (0.3%) anisocoria. There was an 
overall referral rate of 11.9% using the SPOT™. Terveen, Moser, and Spencer also found a 
cost benefit of early amblyopia screening. If left untreated, amblyopia can diminish a 30-year, 
income in South Dakota, by $281,510.00. The 30-year loss was generalized to be 
approximately a $23 million yearly loss in earning power for the western South Dakota area 
workforce.  
Conclusion of Terveen, Moser, and Spencer (2015) was early detection and treatment 
result in quicker outcomes as effectiveness of treatment has been shown to decrease as 
children get older. Also, early detection with early treatment has been shown to decrease length 
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and cost of treatment. Medium ranking was given to this source for critical appraisal. The aim of 
the research was clearly stated. The qualitative methodology was appropriate for this study and 
appropriate to address the aims of the research. Statistical analysis was performed to show 
abnormal screening results and percent of individuals referred with the reason for referral. 
However, no statistical analysis was performed to show sensitivities and specificities of the 
SPOT™ photoscreener. Bias considerations were also not discussed in regard to the role of the 
researchers but researchers did discuss poor follow-up accounting for inability to calculate and 
compare date to cycloplegic retinoscopy. 
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Table 2.2  
Levels of Evidence
 
Author(s), 
Level of 
Evidence 
 
Population 
Setting 
 
Design, Intervention(s) 
 
Outcomes 
 
Appraisal Score 
Arnold, R. 
W., & 
Armitage, D. 
(2014)  
 
Level II 
108 Children 
ages 1 to 12 
years in 
Alaska 
Pediatric Eye 
Practice 
Random Controlled Trial 
 
Pediatric Eye exams performed 
using four different photoscreeners 
(GoCheckKids™, PlusOptix S09™, 
SPOT™, iScreen 3000®) 
 
Each patient was screened using 
four different automated vision 
screeners in random order by 
orthoptist and pediatric 
ophthalmologist. Orthoptist and 
pediatric ophthalmologist did not 
know results of any previous 
readings 
 
 
Each photoscreener had sensitivity 
and Specificity as well as positive 
predictive values >80% except the 
iScreen® screener 
 
 
 
 
Medium 
 
Interpreter of visual images 
was not completely blinded to 
patient identities 
 
Researchers were not 
accustomed to the 
GoCheckKids™ screening 
tool 
 
Individuals screened were 
attending an eye clinic, may 
not be good representation of 
general pediatric clinic 
population 
 
Statistical outcomes were 
given. Validation statistics 
using a 2X3 table to show 
sensitivity and specificity of 
each photoscreener used. No 
in-depth statistical analysis 
 
Good information with 
sensitivities and specificities 
were provided for each 
photoscreener 
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Author(s), 
Level of 
Evidence 
 
Population 
Setting 
 
Design, Intervention(s) 
 
Outcomes  
 
Appraisal Score 
Chang et al., 
2015 
 
 
Level VI 
 
137 Preschool age 
at six different 
preschools in 
O’ahu Hawai’i. Age 
range 8 months to 
5 years 2 months 
 
Race included 48 
full/part Hawaiian 
or Pacific Islander, 
56 mixed races, 21 
Asian, 12 
Caucasian 
Cross-sectional study design 108 preschoolers (79%) passed 
the screening 
 
4 referred for astigmatism 
4 referred for hyperopia 
1 referred for gaze asymmetry 
2 referred for anisometropia 
 
Sensitivity and specificity data 
were not obtained due to lack of 
follow-up for referrals 
 
Photo screener was quick and 
easy to use and well tolerated by 
pre-school children 
Low 
 
Research design was appropriate 
for the aims of the research 
 
Recruitment strategy was 
appropriate for aims of research 
design 
 
Fall out was not listed 
 
Small population size 
 
Environments for screenings 
varied; lighting was not taken into 
consideration when setting up 
screening stations 
 
No in depth statistical analysis 
discussed with sensitivities, 
specificities, CI, OR 
 
Poor follow-up to compare and 
calculate results from cycloplegic 
retinoscopy  
 
Did offer good information on 
results in general and tolerability 
for screeners and screeners 
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Author(s), 
Level of 
Evidence 
 
Population 
Setting 
 
Design, Interventions 
 
Outcomes 
 
Appraisal Score 
Donahue, S. 
P., Arthur, 
B., Neely, D. 
E., Arnold, R. 
W., Silbert, 
D., & Ruben, 
J. B. (2013, 
February)  
 
 
Level IV 
Pediatric 
preschool 
population (12 
months to>72 
months) 
Prospective population-based 
study review 
 
Six physicians on behalf of 
American Association for 
Pediatric Ophthalmology and 
Strabismus developed new 
guidelines to improve reporting 
of results and comparison of 
technologies of detecting 
amblyopia. To propose levels for 
detecting amblyopia risk factors 
to separate those children who 
are at most risk with those 
children who are not 
Prevalence of amblyopic risk factors 
higher than previously thought at 15% 
to 20%  
 
Vision screenings should take place at 
several intervals during early 
development years instead of 1 
particular time in early childhood 
 
Recommendation/Guidelines updated:  
 
Detection of amblyopia risk factors in 
toddlers (12-30 months) 
 
Detection of amblyopia risk factors 
early in preschool children (31-48 
months) 
 
Detection of amblyopia risk factors in 
late preschool and kindergarten 
children 49-72 months 
 
Detection of amblyopia risk factors in 
school-aged children (>72 months) 
 
Detection of amblyopia and decreased 
visual acuity using traditional 
(Optotype-based) screening 
 
Detection of amblyopia and decreased 
visual acuity using instruments other 
than photoscreeners and 
autorefractors 
 High 
 
Valid development strategy 
was explicit & sensible; used 
impartial process to identify 
and select evidence; was 
used for review to improve 
guidelines 
 
Guidelines did not make 
specific, explicit 
recommendations but 
recommendations applicable 
to general practices 
performing vision screenings 
 
Was not noted if guidelines 
were subject to peer review 
 
Each guideline was tagged by 
strength of evidence which it 
was linked with scientific 
evidence  
 
Recommendations provided 
for use in national arena of 
providers; recommendations 
were clinically relevant, listing 
outcomes that can be 
measured through standard 
of care 
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Author(s), 
Level of 
Evidence 
Population 
Setting 
Design, Intervention(s), 
Comparisons 
Outcomes and 
Effect Measures 
Appraisal Score 
Mu, Y., Bi, H., 
Ekure, E., 
Ding, G., Wei, 
N., Hua, N., ... 
Li, X. (2016, 
February 16) 
 
 
Level III 
Pediatric 
population 
ages 4 to 7 
years at 
Tianjin 
University 
Hospital eye 
clinic in 
Helsinki 
 
155 children 
attending 
eye hospital 
for 
screening or 
a check-up 
were 
screened 
 
 
Non-randomised control trial  
 
Compare visual screening with Spot 
photoscreener to traditional 
cycloplegia retinoscopy 
 
 
 
 
155 were screened, 71 were girls, 
84 were boys; 26 (16.8%) had 
amblyopia risk factors. 115 (74.2%) 
had amblyopic risk factors; 65 had 
hyperopia, 28 had myopia, 59 had 
astigmatism, 32 has anisometropia, 
and 37 had strabismus 
 
Wilcoxon signed-rank test showed 
difference was not statistically 
significant at a p value of <0.01 
 
Linear, quadratric, cubic models 
were constructed to assess 
correlation between the two 
screenings  
 
Bland-Altman showed moderate 
agreement between the SPOT 
photoscreener and cycloplegic 
retinoscopy  
 
Spot showed high sensitivity 
(94.79%) and specificity (85%) in 
detecting amblyopia risk factors 
based on AAPOS 2013 guidelines  
 
High 
 
Aim of research was clear 
 
Ethical and bias issues were 
addressed  
 
Statistical analysis was 
discussed in detail 
 
Limitation noted: population 
screened had a high 
prevalence of amblyopia risk 
factors compared to 
community population or 
school based samples as 
screening took place at 
ophthalmology clinic 
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Author(s), Level 
of Evidence 
 
Population 
Setting 
 
Design and Intervention(s) 
 
Outcomes 
 
Appraisal Score 
Oregon 
Evidence-based 
Practice Center 
(2011)  
 
 
 
Level I 
Children 
ages 1-5 
Systematic review 
 
Looking at randomised trials and 
controlled observational studies that 
evaluated screening for impaired visual 
acuity in preschool aged children 
 
Looking at randomised trials and 
controlled observational studies that 
reported outcomes associated with 
treatments 
 
Two independent investigators 
assessed study quality 
Reviewers found: No randomised 
control trials compared preschool visual 
screenings to no preschool screenings 
 
One study found repeated screening, 
from ages 8 months to 37 months, most 
likely reduced amblyopia by age 7.5 
years  
 
One study found a one-time vision 
screening at age 37 months had no 
significance difference at risk for 
amblyopia by age 7.5 years compared 
to no screening  
 
No screening test had both high 
sensitivity and high specificity 
 
3 studies showed preschool age 
children w/ amblyopia or unilateral 
refractive error receiving treatment 
resulted in small improvement at 5 
weeks post treatment or after 1-year 
post treatment but improvement was 
noted 
 
Conclusion: more evidence needed to 
compare early screening and treatment 
to later screening and treatment of 
visual problems such as amblyopia or 
refractive error 
High 
 
Clearly addressed 
focused questions 
 
Large assortment of 
study trials was 
included 
 
Detailed rigor of 
studies included with 
overall results listed 
in review 
 
All important 
outcomes were 
considered 
 
Did report limiting 
factor as studies 
were done within a 
specific community 
setting or 
ophthalmology 
setting which might 
be limiting as may 
not apply to general 
pediatric clinic 
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Author(s), Level 
of Evidence 
 
Population 
Setting 
 
Design, Intervention(s) 
 
Outcomes  
 
 
Appraisal Score 
Powell, C., & 
Hatt, S. R. 
(2009) 
 
 
Level I 
Pediatric 
population 
Systematic review 
 
Randomised controlled trials, 
cluster-randomised trials 
 
To review and evaluate vision 
screening and its results on 
amblyopia compared to non-
screened pediatric population 
 
Two authors independently 
assessed summaries of 
electronic search results 
1449 total articles identified 
 
3 articles were kept 
 
None were randomised controlled trials 
 
Information obtained is from observational 
studies 
 
Prevalence of amblyopia was measured; 
Preschool group had slightly better 
outcomes reported in treatment compared 
to school age children treated  
 
No screening protocol clarified 
 
Determined more evidence needed 
High 
 
Clearly addressed 
focused questions  
 
Best studies were used 
 
Multiple databases 
were used to find 
sources 
 
Rigor used to assess 
quality of studies found 
 
Overall: results were 
clear 
 
Specific statistical 
analysis (CI, OR) were 
indicated 
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Author(s), 
Level of 
Evidence 
 
Population 
Setting 
 
Design, Intervention 
 
Outcomes and 
Effect Measures 
 
Appraisal Score 
 
Singman, E., 
Matta, N., 
Fairward, A., & 
Silbert, D. 
(2013) 
 
Level III 
Autistic 
pediatric 
population, 
ages <1yr to 
15 yr., with 
average age 
of 6 years 
 
48 children 
were 
identified 
with autism 
for this study, 
25 were final 
number 
screened 
Retrospective medical records 
review  
 
Children were tested 2 times 
 
Goal was to compare reliability of 
PlusOptix photoscreener to 
traditional pediatric vision screen 
in a pediatric population with 
autism 
17 (68%) were found to have amblyopia 
risk factors 
 
2nd testing found the same 17 with 
amblyopia risk factors 
 
PlusOptix photoscreener was found to 
have sensitivity of 88%, specificity of 87%, 
positive predictive value of 94% and 
negative predictive value of 78% 
 
Conclusion by Singman et al = is difficult to 
get reliable screening results in children 
with autism; the PlusOptix vision screener 
provides a quick and reliable way of 
screening  
 
Low 
 
Aim of the research 
was clearly stated 
 
Qualitative 
methodology was 
appropriated to 
address aims of the 
research 
 
Data were gathered in 
a way to address the 
research question 
 
Biases, limitations, and 
ethical issues were not 
discussed  
 
No statistical analysis 
information was 
detailed with 
sensitivities, 
specificities, false (+), 
false (-), PPV or NPV, 
CI, OR 
 
No in-depth discussion 
on how findings relate 
to other studies in 
literature 
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Author(s), 
Level of 
Evidence 
 
Population 
Setting 
 
Design, Intervention(s) 
 
Outcomes  
 
 
Appraisal Score 
Terveen, D. C., 
Moser, J. M., & 
Spencer, T. S. 
(2015)  
 
 
Level VI 
Children 
ages 6 
months to 12 
years (mean 
age was 79 
months) 
were 
screened by 
trained Lions 
Club 
volunteers 
using Spot 
photoscreen
er 
 
Final group 
of 4722 
children 
screened, 
2373 were 
female, 2349 
were male  
 
Took place in 
five different 
community 
locations by 
Lions Clubs 
in western 
South 
Dakota 
Quantitative descriptive design 
 
Indications using Spot 
photoscreener indicated no 
follow-up or referral for 
complete eye exam 
 
Data stratified by age group; 4 
different age groups: 12-30mo, 
31-48mo, 49-72mo, 73-144mo; 
Data stratified for sex and 
percentage of children referred 
for hyperopia, myopia, 
astigmatism, anisocoria, 
anisometropia, and ocular 
misalignment 
 
Sex was compared using chi-
squared test  
 
 
 
563 failed the screening 
 
No significance difference in referrals 
based on sex (p=0.598) 
 
Children 73-144 months had highest 
referral rate (12.2%); 12-30 months 
had lowest referral rate (7.9%) 
 
Reasons for referral: 371 (7.9%) 
astigmatism, 24 (0.5%) ocular 
misalignment, 101 (2.1%) 
anisometropia, 135 (2.9%) myopia, 
36 (0.8%) hyperopia, 16 (0.3%) 
anisocoria 
 
11.9% overall referral rate using Spot 
screener 
 
Cost benefit of amblyopia was found 
to be favorable, showing untreated 
amblyopia can diminish a 30-year 
income by $281,510.00; 
 
 
 
 
Medium 
 
Aim of the research was 
clearly stated 
 
Qualitative methodology was 
appropriate for this study and 
appropriate to address the 
aims of the research.  
 
Statistical analysis was 
performed to show abnormal 
screening results and percent 
of individuals referred with 
reason for referral 
 
No statistical analysis was 
discussed to show sensitivities 
and specificities of the SPOT 
photoscreener 
 
Bias considerations were not 
discussed in regard to the role 
of the researchers; did discuss 
poor follow-up accounting for 
inability to calculate and 
compare date to cycloplegic 
retinoscopy 
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Author(s), 
Level of 
Evidence 
 
Population 
Setting 
 
Design, Intervention(s) 
 
Outcomes 
 
 
Appraisal Score 
U.S Preventive 
Services Task 
Force. (2011)  
 
 
Level IV 
 
Pediatric 
population, 1 
to 5 years of 
age 
Summary recommendations for 
vision screening in children 
Recommends vision screening all 
children ages three to five years of 
age with Grade B evidence 
 
Found adequate evidence of benefits 
of early detection and treatment of 
amblyopia improves visual outcomes 
with moderate certainty in ages 3 
years to 5 years 
 
Limited evidence on harms of vision 
screenings 
 
Adequate evidence of early 
treatment of amblyopia in children 
younger than 3 years leads to 
improved outcomes  
 
Did not find adequate evidence for 
recommendations of intervals for 
vision screening   
 
Found screening and treatment later 
in preschool years appears to be 
effective but may take longer to treat 
increasing financial burden 
 
High 
 
Used valid development 
strategy which was explicit and 
sensible; Used impartial 
process to identify and select 
evidence 
 
Guidelines did not make 
specific, explicit 
recommendations; 
recommendations were 
applicable to general practices 
of vision screenings 
 
Was not noted if the guidelines 
were subjected to peer review  
 
Each guideline was not tagged 
by strength of evidence in 
which it was linked with 
scientific evidence  
 
Updated guidelines provide for 
use in the national arena of 
providers which were clinically 
relevant; outcomes listed can 
be measured through standard 
care 
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Author(s), 
Level of 
Evidence 
 
Population 
Setting 
 
Design, Intervention(s) 
 
Outcomes 
 
 
Appraisal Score 
Yan, X., 
Jiao, W., 
Li, Z., Xu, 
W., Li, F., 
& Wang, L. 
(2015, 
June 1)  
 
 
Level III 
 
 
Children ages 
2 to 14 years 
attending an 
ophthalmology 
clinic at 
Provincial 
Hospital in 
Shandong 
Helsinki 
 
178 pediatric 
patients 
(100 males, 78 
females) 
Controlled trial without randomization 
 
To assess the accuracy of PlusOptix 
A09 photoscreener in detecting 
amblyopia risk factors in children 
 
Comprehensive ophthalmic exam in 
order: PlusOptix A09, orthoptic exam 
with prism alternative and cover test, 
anterior segment assessment using 
slit lamp, fundus exam with 
cycloplegic retinoscopy 
 
Data analysis to compare refractive 
measurements between PlusOptix 
and cycloplegic retinoscopy were 
calculated 
 
 
 
 
 
86 (48.3%) children diagnosed with 
amblyopia 
 
63 (35.4%) children diagnosed with 
strabismus 
With mean deviation of 27.1 ± 18.5 PD 
 
Sensitivity for detecting refractive 
amblyopia risk factors was 80.6% 
 
Specificity for detecting refractive 
amblyopia risk factors was 76.3% 
 
After applying ROC curve, overall 
sensitivity of PlusOptix A09 in detecting 
refractive amblyopia was 94.9% and 
specificity for detecting refractive 
amblyopia was 63.2% 
 
Spherical equivalent showed significant 
difference between PlusOptix and 
cycloplegic retinoscopy with p = 0.00 
 
Paired t-test showed p = 0.14 for mean 
cylinder power value (Jackson cross 
cylinder at axis 0 0) and p = 0.26 (Jackson 
cross cylinder at axis 45 0) 
 
Bland-Altman plots showed agreement 
between the PlusOptix A09 and 
cycloplegic retinoscopy for spherical 
equivalent 
High  
 
Aims of research clearly 
stated with appropriate 
methodologies applied 
 
Recruitment was clearly 
stated with reasons for 
exclusions 
 
Data collection was clearly 
reported 
 
Potential bias: population was 
already attending eye clinic. 
May not be easily applied to 
general pediatric clinic 
population 
 
Ethical issues were 
considered  
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Consistency measurements from 
PlusOptix A09 and cycloplegic retinoscopy 
confirmed with Pearson’s correlation 
coefficient (r = 0.95, p = 0.00) 
 
Conclusion = PlusOptix A09 is useful in 
large scale screenings of refractive errors 
but may not be suitable for large scale 
strabismus screening 
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Construction of Evidence-based Practice 
Synthesis of Critically Appraised Literature 
Amblyopia is the most common visual disorder in children and is potentially curable if 
detected early and treated properly in the first few years of life. Amblyopia is the leading cause 
of monocular vision loss in children (Bradfield, 2013). Other visual abnormalities include 
refractive errors such as myopia, hyperopia, and astigmatism causing blurring of vision. 
Retinoblastoma is another vision concern requiring early screening to detect and mitigate before 
it causes long term effects (Hered, 2011). In children, visual impairment can delay learning 
causing children to be inadequately prepared to start preschool or kindergarten. Delayed 
detection of visual problems can lead to neural visual pathways not developing properly 
therefore causing irreversible vision loss (AAP, AACO, AAPOS, AAO, 2003; Bradfield, 2013; 
Chang et al. 2015; Forcina et al., 2017; Hered, 2011; USPSTF, 2011).  
It has been shown in the literature that early detection and treatment of amblyopia and 
amblyopic risk factors between the ages 3 years and 5 years lead to improved visual outcomes 
and has moderate net benefit (USPSTF, 2011). Sources reveal early detection, especially in 
preschool years, of vision abnormalities can result in full recovery of vision and decrease 
developmental abnormalities of binocular vision (AAP, AACO, AAPOS, AAO, 2003; Bradfield, 
2013; Forcina et al., 2017). 
Data within the literature demonstrated automated visual screening instruments, also 
known as photo screeners, have become more accurate at detecting visual abnormalities 
specifically amblyopia, amblyopia risk factors, refractive errors, and strabismus in the pediatric 
population, ages six months to five years (Arnold & Armitage, 2014; Mu et al., 2016; Powell & 
Hatt, 2009; Singman et al., 2013; Yan et al., 2015). AVS provide practical, fast, and easy vision 
screenings. Most AVS screen both eyes simultaneously, accommodating a short attention span 
of a young, non-verbal child or a child with autism or learning disabilities (Bradfield, 2013; 
Peterseim et al., 2015; Terveen, Moser, & Spencer, 2015; Yilmaz et al., 2015).  
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PlusOptix™ photoscreeners have been shown in the literature to have a high sensitivity 
for detecting amblyopia and amblyopic risk factors and specificity for detecting those individuals 
without amblyopia and amblyopic risk factors (Mu et al., 2016; Singman et al., 2013). Singman, 
Matta, Fairward and Silbert (2103) reported the PlusOptix SPOT™ photoscreener to have a 
sensitivity of 88% and a specificity of 87% for detecting individuals with and without amblyopic 
risk factors. Mu et al. (2016) reported the PlusOptix™ photoscreener having a sensitivity of 
94.79% and specificity of 85% for detecting amblyopic risk factors.  
Overall results from literature show that automated photoscreeners, including the 
PlusOptix™ series, are easy to use, time-saving, have good compliance with children, and are 
accurate in detecting visual abnormalities in the young pediatric clients.  
Best Practice Model Recommendation 
Based on the evidence, children ages six months to five years need early vision 
screening for early detection of amblyopia, amblyopia risk factors, strabismus, and 
retinoblastoma to prevent long term vision loss. Using the evidence found in the literature, the 
project manager used Nola Pender’s HPM and the Stetler evidence practice model to guide the 
new clinical practice change. The EBP project incorporated automated visual screeners, the 
PlusOptix™ in particular, into well child exams within pediatric clinics located in a large Midwest 
city.  
Vision screenings took place using the PlusOptix™ at ages 9 months, 24 months, 36 
months, and 48 months. Boxes were created by IT in the EHR under the visual screening tab for 
nurses to document “pass” and “refer” from the PlusOptix™ results. A copy of the results from 
the PlusOptix™ were printed and placed in the patient’s EHR. The printout contained specific 
abnormalities found from the screening. Any failed vision exams were referred to onsite 
ophthalmology or ophthalmology of the parents’ choice. The project leader followed-up with 
patients, via EHR, who were referred to ophthalmology to compare traditional eye screening 
results to the printed results of the PlusOptix™. The EBP project leader also compared 
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PlusOptix™ results on a set number of patients over three months using the PlusOptix™ in the 
clinic setting to three months of vision screening referrals prior to implementation of the 
PlusOptix™. This comparison helped provide evidence on the accuracy of the PlusOptix™ 
within the clinic setting by comparing referral rates of the pre-implementation group to the post-
implementation group and showing sensitivity.  
How the Best Practice Model Will Answer the Clinical Question 
The best practice recommendation answered the clinical question: In a pediatric 
population aged 9 months, 24 months, 36 months, and 48 months, how does early vision 
screening using automated photo vision screeners compared to traditional vision screening 
techniques affect the number of refractive errors detected within three months. The hope was by 
performing vision screenings with the PlusOptix™ in the stated population then comparing the 
results to the results of vision screenings performed by traditional screening methods, prior to 
the use of the PlusOptix™, the clinical question would be answered.   
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CHAPTER 3 
IMPLEMENTATION OF PRACTICE CHANGE  
Participants and Setting 
 A total number of 322 preschoolers were recruited in the sample with 161 in each 
the pre- and post-implementation groups. It was estimated 100 pediatric patients would be 
screened in the post-implementation group based on the number of WCC from the previous 
year in the same three months. Pre-implementation vision information was obtained from EHR 
once post-implementation data was collected and the number was known with the assistance of 
IT personal at the clinic site. The pre-implementation group was identified based on age groups, 
WCC, and same providers as the post-implementation group. One-hundred-sixty-one WCC 
were performed in the post-implementation group using the EBP project parameters, therefore 
that became the size of each sample group.  
The setting for this EBP project was a general pediatric clinic in a large Midwest city. The 
pediatric clinic is part of a large not-for-profit organization that sees clients of various ethnic and 
socioeconomic backgrounds. There are six different pediatric clinics with many pediatric 
providers. However, only one clinic and two providers WCC information was used to collect data 
regarding vision screening results and referrals. Participants were pediatric clients in the clinic 
for a well-child check at ages 9 months, 24 months, 36 months, and 48 months.  
 Data collected post-implementation was to show the specificity and sensitivity of the 
PlusOptix™ comparing vision screening results to the pre-implementation group. The project 
was to compare data of vision screenings using the PlusOptix™ over a 3-month period to vision 
screening results using traditional visual screening methods performed by pediatric providers 
from three months prior to implementation of the PlusOptix™ in order to compare referral rates. 
Data collected post-implementation of the PlusOptix™ also compared screening results from 
failed PlusOptix™ screenings to ophthalmology screenings after being referred by the pediatric 
provider to look at sensitivity.   
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Outcomes 
Data collection took place over a three-month period. Data collected post-
implementation of the PlusOptix™ was compared to data collected from screening results 3 
months prior to implementation of the PlusOptix™. Data were also collected from 
ophthalmology referral results post-implementation and compared to the child’s PlusOptix™ 
results. It was believed the data collected would show ability of the PlusOptix™ photoscreener 
to detect visual abnormalities, specifically amblyopia, and amblyopic risk factors accurately at 
the early ages of 9 months, 24 months, 36 months, and 48 months. Data analysis on these two 
groups was to show accuracy, specificity, and sensitivity.  
Intervention 
Vision screenings took place in the above-mentioned Midwest pediatric clinic using the 
PlusOptix™ at ages 9 months, 24 months, 36 months, and 48 months. Data collected was not 
only to show specificity and sensitivity of the PlusOptix™ but also to show accuracy in the age 
groups 9 months, 24 months, 36 months, and 48 months. The previous traditional visual 
screenings at WCC included the Snellen chart starting at age 4 years by some pediatric 
providers and at kindergarten age by other pediatric providers. Vision problems are difficult to 
screen for in this age group using traditional eye charts due to the child’s preverbal 
development, the inability to recognize objects and letters, and the inability to cooperate due to 
age and attention span. Previously, Snellen chart screenings were also done at sports physical 
check-ups or if there were a concern by a parent, teacher, or other contact person of the child. 
At all WCC, a visual exam by the provider was performed without the use of cycloplegia 
retinoscopy as cycloplegia is typically done in an ophthalmology clinic. Screening with 
PlusOptix™ offers the advantage of being able to fully screen the 9 months, 24 months, 36 
months, and 48 month age groups, thereby increasing the available data starting at an earlier 
age. Limitations of traditional vision screenings methods of Snellen chart and pediatric provider 
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visual exams during WCC had prevented children in these age groups from being fully screened 
for refractive errors at this clinic. 
Boxes was created by IT in the electronic health record (EHR) under the visual 
screening tab for nurses to document “pass” or “refer.” Nurses were to check the appropriate 
box once screening was completed using the PlusOptix. ™ This documentation screen was also 
used to generate billing for the screenings. If documentation does not occur in this screen, a 
patient or their insurance is not billed. If the child was unable to be screened the nurse had the 
option to long hand document in the vision screening tab that information and why they were not 
screened. The nurse was to use the word “NULL” on the project flow sheets if a child was not 
screened or was unable to be screened and give the reason such as small eyes, uncooperative, 
or already seeing ophthalmology.  A copy of the results from the PlusOptix™ was printed and 
placed in the patient’s EHR. The printout contained specific abnormalities found from the 
PlusOptix™ screening. Any failed vision exams were referred to onsite ophthalmology or an 
ophthalmology of the parents’ choice. Data were collected over three months post-
implementation of the PlusOptix™ using flow sheets in the clinic and by EHR. Data were also 
collected for three months pre-implementation for comparison. The project leader followed-up 
with patients, via EHR, who were referred to ophthalmology to compare ophthalmology eye 
screening results to the child’s PlusOptix™ “refer” printed results kept in the child’s EHR. The 
comparison was to show sensitivity and specificity of the PlusOptix™.  
Planning 
Approval to implement the PlusOptix™ was granted by the medical board, which 
governs policies and procedures for the pediatric clinics, after best practice evidence 
information was provided. Initial request for the PlusOptix™ was presented along with 
information received from current literature to pediatric providers working within the pediatric 
clinics. Information from the literature was disseminated to providers and a capital request form 
was filled out and submitted by nursing administration. After receiving feedback from providers 
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and nursing administration, evidence was presented to the medical board where approval was 
granted for the use of the PlusOptix™ vision screener within the pediatric clinics.  Approval was 
also obtained by Valparaiso University and the project facility’s Internal Review Boards. 
Staff education was conducted by selecting superusers from each clinic. Superusers 
were chosen based on those who volunteered to be trained as such. The project manager, 
nursing administration, and superusers received formal education on the PlusOptix™ 
photoscreener via Skype® from a PlusOptix™ Inc consultant. There was also a PowerPoint® 
that was part of the training by the PlusOptix™ representative as well as online videos walking 
the viewer through the process of using the PlusOptix screener™. The videos included use, 
meaning of test results, maintenance, and troubleshooting of the PlusOptix™. Individual staff 
members within the individual clinics were trained with the use of the online videos provided by 
PlusOptix™. The staff members watched the videos and reviewed the PowerPoint® during a 
staff meeting and those who were not able to attend the staff meeting set up a time with the 
project manager or supervisor to watch the training videos and demonstrate competency. 
Competency was checked off using an attendance roster flow sheet (see Appendix A) as each 
staff member accurately demonstrated back proper use, cleaning, and storage of PlusOptix™. 
Staff members were also required to demonstrate proper use of the photoscreener on a 
superuser or the project manager and on one patient. A “cheat sheet” (Quick reference guide) 
provided by PlusOptix Inc™ (see Appendix B) was given to each staff member with use and 
meaning of vision screening results. A copy of the “cheat sheet” was also kept with the 
PlusOptix™ for easy access while using the photoscreener.  
Data 
Measures 
One group in which data were collected was the portion of patients where refractive 
errors were detected by the PlusOptix™ (post-implementation). Post-implementation data of 
failed screenings was compared to visual screening results from ophthalmology after referral 
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was made. The project manager was able to access and follow-up on ophthalmology results via 
EHR if the child was seen by ophthalmology within the same organization. If a child was not 
seen for referral within the same organization, referral results were unknown. Another group 
was the portion of patients screened, pre-implementation of the PlusOptix™ by pediatrician’s 
visual exam and Snellen Chart. Pre-implementation group data were chosen randomly with the 
help from IT. A chi-square goodness of fit test was performed to check which group would find 
more refractive errors. A chi-square test was also performed to test for any significance of 
results based on gender or race. An independent-samples t-test was performed to test for 
differences between both groups based on age. Both sets of data were normally distributed and 
measured using the same criteria of pass or refer, and number of failed screenings found 
between the PlusOptix™ post-implementation and the traditional screening pre-implementation.  
Data collected was statistically analyzed after input into the most current SPSS system, 
a computer program for statistical analysis. 
Collection 
Data collection post-implementation was tracked by flowsheets in the pediatric clinic. 
One flowsheet contained four columns; one for the medical record number, one for DOB, one 
for PlusOptix™ results (pass, refer), and one for an assigned identification number (IDN), (see 
Appendix C). Another flow sheet contained four different columns to de-identify data; one 
column for IDN, one for the PlusOptix™ results, one for the Ophthalmology results if referred, 
and one for DOB (see Appendix D). The same flow sheets were created for pre-implementation 
data (see Appendices E & F). PlusOptix™ screenings and screening results were also kept in 
each child’s EHR.  Screening results scanned into the patient’s chart from the PlusOptix™ 
contained detailed results such as eye/pupil measurements, alignment and refractive errors. 
Nursing staff recorded patient’s medical record number, date of birth, pass, refer, or NULL on 
the flow sheets of children within the specified age group having visual screenings with the 
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PlusOptix™. If “NULL” was listed in the results column a notation was made as to why no 
results were obtained such as uncooperative or eyes too small.  
The project manager assigned an IDN once the flowsheet had been filled or at the end 
of data collection whichever came first. Nursing staff also recorded results in the correct location 
of each child’s EHR. A printed copy of the PlusOptix™ results from the remote PlusOptix™ 
printer was scanned into the EHR and became a permanent part of the EHR. Once results were 
documented within the patient chart, the project manager used the flowsheet to locate the 
results. Vision screening results were obtained from the same number of charts, within the 
same age groups, on children receiving screenings during WCC, 3 months prior to 
implementation of the PlusOptix™. Charts were chosen randomly with assistance from IT.  
Some post-implementation data were obtained solely from the EHR with the assistance of IT as 
implementation of the PlusOptix™ was implemented by providers prior to full IRB approval for 
data collection by the project site. IRB approval was given for this process as well. Pre-and 
post-implementation data were compared to determine referral rates of detecting refractive 
amblyopic risk factors between the two groups. PlusOptix™ failed results were compared to 
ophthalmology results to help show sensitivity and specificity.  
Management and Analysis 
 Management of the flowsheets was taken into great consideration as to not compromise 
the identity of each child screened. The initial flowsheet was securely located in a locked 
cupboard with the PlusOptix™ at the nurse’s station at the end of each clinic day. The second 
flowsheet, that the project manager used, was kept in a locked file cabinet in the supervisor’s 
office when the project manager was not on site. The only patient identifiers on the flow sheets 
were DOB and medical record number. 
 Once all data were obtained the project manager reviewed all data collected by 
comparing data on the flowsheets to data within each individual’s chart. The project manager 
also reviewed appointment schedules for the three months post-implementation to make sure 
SCREENING AMBLYOPIC FACTORS 57 
 57 
no WCC visual screenings were missed on the data collection flow sheets. Data were then 
organized using an SPSS code book so data could be entered into the most current version of 
SPSS for analysis. 
  A chi-square test was performed to compare the two groups and show referral rates. It 
also looked at statistical differences based on gender and race. An independent-samples t-test 
was performed using data collected in order to show if there was a statistical difference based 
on age between the two groups.  
 Any follow up/referrals seen outside the clinics network were inaccessible for review and 
comparisons.  
Protection of Human Subjects 
Institutional Review Board (IRB) approval was obtained from Valparaiso University and 
the project facility’s IRB prior to implementing this EBP project. There were no patient identifiers 
transcribed on any written material or stored in any databases, spreadsheets, or word 
documents. No protected health information (PHI) was put into the PlusOptix™, which is 
possible with this screener so patient data can be directly uploaded into the patient’s chart. By 
not imputing PHI into the PlusOptix™ patient information is protected in the event the vision 
screener became missing or stolen. Flowsheets with patient medical record number and DOB 
were kept in a locked cupboard at the nurse’s station and in the supervisor’s office at the end of 
each clinic day so it is easily accessible to the nursing staff and the project manager but secure 
to protect information. The project leader was able to locate patient’s vision screening results 
within the EHR by using medical record number information and DOB from the flowsheet. The 
project leader was also able to track referrals to ophthalmology through the EHR and follow-up 
screenings if done within the same facility so no release of information was needed by parents 
or guardians. Follow-up results for anyone seeing ophthalmology outside of the clinics network 
were inaccessible for comparison.  
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CHAPTER 4 
FINDINGS 
 The PICOT question for this project was: In a pediatric population aged 9 months, 24 
months, 36 months, and 48 months, how does early vision screening using an automated photo 
vision screener, compared to traditional vision screening techniques affect the number of 
refractive errors detected within three months? The purpose of this EBP was to implement an 
automated visual screener at all well-child visits for the ages listed within the PICOT question to 
check for amblyopia risk factors and refractive abnormalities. Pre-implementation screenings for 
these age groups were performed by the provider using ophthalmoscope without cycloplegic 
retinoscopy (pupil dilatation). Snellen chart was used only for those receiving a kindergarten 
well check. No Snellen chart screenings were used on the age groups listed above unless there 
was a concern by a parent, legal guardian, or school program. Screening for these age groups 
post-implementation was performed using the PlusOptix S12™ automated visual screener.  
This chapter provides data on the participants’ characteristics using descriptive statistics, 
independent t-test, as well as the Chi-Square Goodness of Fit test for the outcome measure.  
Participants 
Size and Characteristics 
 This EBP practice project was implemented in a Midwest pediatric clinic during well-child 
check-ups for ages 9 months, 24 months, 36 months, and 48 months. It included all children in 
these age groups from different genders and races. No one was excluded. Data were captured 
on those that were unable to be screened due to lack of cooperation, already seeing 
ophthalmology, or some other reason not documented and recorded as “NULL” on the data 
collection flow sheet. 
A total of 322 children were recruited in the sample size with 161 children in each the 
pre- and post-implementation groups. Three were lost to attrition in the pre-implementation 
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group (final n = 158) and 14 in the post-implementation group (final n = 147). Attrition from these 
groups was due to unwillingness to cooperate with the screening (0% pre-implementation 
group; .01% post-implementation group), they were already being followed by ophthalmology 
(2% pre-implementation group; 2% post-implementation group), or unknown reasons (0% pre-
implementation group; 6% post-implementation group) as it was not documented by the nurse 
why the visual exam was not performed. Those individuals not screened were documented as 
“Null” in the dataset for input into SPSS and documented as “attrition” on final charts and 
figures. 
No release of information was needed for this EBP project as only chart data were used, 
including any referral follow-up information. Parents were not contacted and reminded to follow-
up with ophthalmology if they had not done so by the end of data collection. Nor were parents 
contacted to see if they had followed-up with ophthalmology at another facility at the end of data 
collection. All pre-implementation referral follow-ups were completed and accounted for. Only 
two of the children screened pre-implementation were referred and did follow-up with 
ophthalmology. Refractive errors were confirmed on follow-up. Out of the (n = 147) post-
implementation group, 16 children were referred to ophthalmology for follow-up. Of the 16 
referred to ophthalmology, seven follow-ups were accounted for and refractive errors confirmed.  
Of the recruited sample size (N = 322), pre- and post-implementation, 24.8% were 9 
months, 30.4% were 24 months, 24.5% 36 months, and 20.2% were 48 months. The majority of 
those screened were 24 months of age (see Figure 4.1). Gender and race were also captured 
for patients in both the pre- and post-implementation groups for comparison in outcomes (see 
Figures 4.2; 4.3).  
Age, gender, and race were compared between the two groups. In order to find if there 
were differences in results between the pre- and post-implementation group based on age an 
independent t-test was performed. The independent t-test found no significant difference (t(2) = 
.086, p > .05) in visual abnormalities among age groups pre- and post-implementation. The 
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mean for age of the pre-implementation group (M = 2.29, SD = 1.05) was not significantly 
different from the mean of the post-implementation group (M = 2.50, SD = 1.07). A chi-square 
test of independence was used to compare the frequency of visual abnormalities among 
genders and races. Gender was found to have no significance in the outcome of visual 
abnormalities (χ2 = .262,a p =>.05). Race was also found to have no significance in frequency 
of visual abnormalities (χ2 = 3.622,a p = > .05) between the two groups.  
Figure 4.1. Ages Groups
 
Figure 4.1. Age group comparisons between pre- and post-implementation samples.  
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Figure 4.2. Gender 
 
 
 
Figure 4.2. Gender comparison between pre- and post-implementation samples.  
 
 
Figure 4.3. Race  
 
Figure 4.3. Race comparison between Pre and Post-Implementation Samples. 
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Changes in Outcomes 
Statistical Testing  
It was anticipated that each refractive error found with the PlusOptix™ would also be 
found with an ophthalmology exam. It was also anticipated that the PlusOptix™ photo screener 
would find more refractive errors than traditional pediatric eye exams, without dilatation, during 
well-child check-ups within the pediatric clinic. Descriptive frequencies were calculated to 
compare the rate of refractive errors found with the PlusOptix™ compared with follow-up 
ophthalmology exams. The Chi-Square Goodness of Fit was used to test if the PlusOptix™ 
photo screener would find more refractive errors than traditional pediatric eye exams. The chi-
square test was chosen for its ability to compare observed frequencies to expected frequencies. 
This test helps the observer decide if there is a real treatment effect or if observations are just 
by chance (Polit & Beck, 2012). The chi-square test was also used to compare frequency of 
visual abnormalities among different genders and races. An independent t-test was used to 
compare the frequency of visual abnormalities among age groups. The independent t-test was 
chosen as it tests the mean of two independent groups to determine if the population means are 
significantly different. It tells the observer if there is a difference and if that difference is true or a 
random effect (Polit & Beck, 2012). All statistical analyses were performed using IBM® SPSS® 
Statistics, version 22.  
Significance 
The PlusOptix S12™ was implemented in a pediatric clinic in the Midwest. The data 
collected post-implementation, using the PlusOptix, ™ were collected over three months and 
compared to visual screening data from three months pre-implementation. Data from the 
PlusOptix™ were also compared to visual screenings performed at ophthalmology follow-up 
screenings to show sensitivity. Specificity could not be calculated as not every child being 
screened during their well-child check-up could be sent to ophthalmology to test for absence of 
disease. This was due to time and funding constraints. Using Chi-Square (χ2) test, a statistical 
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significance was found of the PlusOptix™ to identify more refractive errors than the traditional 
vision screening performed by the PCP during a well-child check-up (χ2) = 20.430a, p < 0.001).  
Of the children (n = 158) screened pre-implementation, two were referred to 
ophthalmology. Both children were confirmed to have some sort of refractive error. Of the 
children (n = 147) screened post-implementation, 16 children were referred to ophthalmology 
but only seven followed-up with ophthalmology (see Figure 4.). All of the seven were confirmed 
to have some sort of refractive error, therefore showing the PlusOptix™ as having 100% 
sensitivity at identifying visual abnormalities in this sample. Each child in the pre and post-
implementation groups passing his/her visual screening was not sent to Ophthalmology to 
confirm normal vision results. Therefore, specificity was not obtainable as specificity is the ability 
of the test to correctly identify no disease.  
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Figure 4.4. Type of Initial Exam Results
 
 
Figure 4.4. Type of Initial exam results pre-implementation (pediatrician) and post-
implementation (PlusOptix™) showing higher referral rate referral with the PlusOptix™.  
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CHAPTER 5 
DISCUSSION 
This EBP project examined the clinical research question: Will an automated visual 
screener detect more refractive errors than traditional visual exams performed by pediatric 
providers during routine well child checks. The goal was to implement the PlusOptix S12c™ 
automated visual photo screeners into the pediatric clinics of a Midwest organization. 
Automated visual screeners were supported by the literature to be sensitive for detecting 
amblyopic refractive errors. Visual screenings were performed using the PlusOptix S12c™ in 
four different age groups (n = 161) during routine well child check-ups. Any “refer” results were 
referred to ophthalmology. The pre-implementation group (n = 161, the same number as the 
post-implementation group) charts/EHR were randomly chosen from three months prior to 
implementation of the PlusOptix™ based on age, well-child check-up, and provider. Both groups 
(N = 322) were compared to help show sensitivity and specificity of the PlusOptix™ This 
chapter will examine the findings, applicability of the theoretical framework, EBP framework, 
strengths and weaknesses of the EBP project, and implications for the future.  
Explanation of Findings 
 The PICOT question asked: “In a pediatric population aged 9 months, 24 months, 36 
months, and 48 months, how does early vision screening using an automated photo vision 
screener, compared to traditional vision screening techniques affect the number of refractive 
errors detected within three months?” 
A total of 322 children were recruited in the sample size with 161 children in each the 
pre- and post-implementation groups. Three were lost to attrition in the pre-implementation 
group (final n = 158) and 14 in the post-implementation group (final n = 147). All pre-
implementation referral follow-ups were completed and accounted for. Only two of the children 
screened pre-implementation were referred and did follow-up with ophthalmology. A refractive 
error or errors were confirmed on follow-up. Out of the (n = 147) post-implementation group, 16 
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children were referred to ophthalmology for follow-up. Of the 16 referred to ophthalmology, 
seven follow-ups were accounted for and refractive errors confirmed.  
A chi-square test was used to analyze data to see if the PlusOptix™ would identify more 
refractive errors than traditional visual exams performed by the PCP without pupil dilatation. The 
chi-square test was also used to look at gender and race in each the pre- and post-
implementation groups to see if there was a significant difference among these characteristics. 
A t-test was performed to compare frequencies of visual abnormalities among the different age 
groups. Sensitivity was also looked at for the PlusOptix™ to compare findings from this EBP 
project to the findings within the literature.  
Statistical analysis using the chi-square test showed statistical significance of the 
PlusOptix™ to identify more refractive errors than the traditional PCP visual exam without the 
use of pupil dilatation (χ2 = 20.430a, p < 0.001). The chi-square test showed no statistical 
significance in the outcome of visual abnormalities by gender (χ2 = .262,a p = >.05) or race (χ2 = 
3.622,a p = > .05). The independent t-test also showed no significant difference in visual 
abnormalities detected among age groups pre- (M = 2.29, SD = 1.05) or post-implementation 
(M = 2.50, SD = 1.07).  
All children failing (n = 16) vision screenings post-implementation (n = 147) using the 
PlusOptix™ automated visual screener and that followed-up (n = 7) with ophthalmology were 
confirmed to have visual refractive abnormalities. After statistical analysis was performed, the 
referral and follow-up rate post-implementation showed the PlusOptix™ to have a sensitivity of 
100% and referral rate of 11%. In the pre-implementation group (n = 156), 2 children were 
referred to ophthalmology and both followed-up. Both children were confirmed to have a visual 
refractive error or errors. After statistical analysis was performed the referral and follow-up rate 
for the pre-implementation group, PCP exams were shown to have a referral rate of 1.3%. 
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Therefore, showing the PlusOptix™ to have a higher referral rate than provider referrals from 
traditional visual exams and a high sensitivity for identifying refractive errors.  
Statistical analysis from this EBP project coincides with information found within the 
literature. Arnold and Armitage (2014) showed the PlusOptix™ as well as other AVS to have a 
sensitivity and specificity greater than 80% at detecting refractive errors. Mu et al. (2016) found 
the AVS used in their research to have a sensitivity of 94.79% and specificity of 85%. Singman 
et al. (2013) reported the PlusOptix™ to have a sensitivity of 88%, specificity of 87%, and was a 
quick, reliable way of screening the pediatric population especially those with autism. Terveen et 
al. (2015) showed an 11.9% referral rate using an AVS and no significance difference in 
referrals based on gender. Yan et al. (2015) also showed the PlusOptix™ to have sensitivity of 
94.9%.   
Evaluation of Applicability of Theoretical and EBP Frameworks 
Theoretical Framework 
The Health Promotion Model (HPM) by Nola J. Pender (Friedman, Bowden, & Jones, 
2003; George, 2011) was used as the theoretical framework to help guide this EBP project. The 
HPM complements other health protection models to enhance health and well-being. It offers a 
process to help motivate individuals to participate in positive behaviors to enhance their health. 
Pender’s HPM stresses the importance of self-direction, self-regulation, and perceptions of self-
efficacy (Friedman, Bowden, & Jones, 2003; George, 2011). The HPM allows for ease of 
applicability by its simplistic stepwise approach 
Pender’s HPM focuses on individual characteristics, experiences, behavior-specific 
cognitions, and one’s affect and behavioral outcomes. The HPM was appropriate for this EBP 
project because the EBP project site prides itself on health promotion and disease prevention. 
Pediatric providers highly recommend routine yearly well-child check-ups. Nursing staff help 
remind parents of this when in clinic or when a parent or patient calls the clinic to speak with a 
nurse. The goal of requiring regular well-child check-ups is to model and promote positive health 
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behaviors. This modeling can lead to overall good health maintenance which can last a lifetime 
and be passed on to family members. The HPM has a holistic focus based in nursing which 
gives it strength by promoting independent practice to provide health promoting interventions 
and education to individuals.  
Implementation of the AVS was one way the providers and nurses could continue to 
promote health and disease prevention. Pender’s HPM suggests if a family perceives a threat 
and there are opportunities for decreasing that threat such as health screenings or vision 
screenings, the family will be more likely to act on it. In this project, children were being seen for 
well-child check-ups and many of them continued to promote health by going to the 
ophthalmology clinic based on individual screening results.  
EBP Framework 
The Stetler Model (SM) provides a stepwise process for gathering sound evidence that 
can guide safe and effective care or evidence-based practice. The SM uses a prescriptive 
approach, emphasizing critical thinking as a key role. The SM relies on five steps which include: 
preparation, validation, comparative evaluation/decision making, translation/application, and 
evaluation (Stetler, 2001).  
Preparedness entails identifying a need, the environment it involves, organizing, and 
initiating evidence research (Ciliska et al., 2011; Stetler, 2001; Young, 2012). It was identified 
within the EBP facility there was a need to offer more in depth visual screenings while children 
were in for well-child check-ups. This would offer an opportunity to promote health and help 
instill the importance of routine visual exams. Eye problems tend to go un-noticed until there are 
developmental delays or struggles in school (Bradfield 2013; Forcina et al., 2017; Koning et al., 
2013); USPSTF, 2011).  
The validation process requires combing through a body of evidence to select evidence 
which best identifies the need for change. For this EBP project, five databases were searched 
for best evidence using search terms identified to reveal the best sources. Four-hundred-twenty-
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nine sources were revealed, with some sources overlapping in the different databases. After 
reviewing abstracts and relevance, 10 sources were kept for final best practice evidence.  
Moving into the next phase is comparative evaluation/decision making. This phase 
involves applying a set of criteria to evidence collected in the validation phase to further decide 
which evidence best identifies or supports the practice change. Evidence for this EBP project 
was appraised and leveled using Melnyk and Fineout-Overholt’s Hierarchy of Evidence and the 
Critical Appraisal Skills Programme© (CASP).  
Translation/application then occurs requiring conversion of evidence findings into 
practice by dissemination, leading to the final phase of evaluation. The translation/application 
process for this EBP began with an initial request for implementation being presented to 
pediatric providers, the facility administration, and the facility medical board along with evidence 
from the literature showing sensitivity and specificity of automated visual screeners. A capital 
request form was submitted to the budget committee to request funding for the PlusOptix™ 
screeners. Approval was granted by the facility medical board to implement the screeners. 
Budget was approved to purchase the screeners. Approval was also obtained from the EBP 
facility IRB and Valparaiso University IRB to implement the project.  
Once approvals were received, formal education was given by the PlusOptix Inc™ 
representative to the project manager, nursing administration and super users. Education on 
use and maintenance of the PlusOptix™ screener via Skype®, PowerPoint®, and online videos 
was included. The clinic nursing staff members watched videos from the PlusOptix Inc™ 
website and performed practice screenings before competency was verified.  
A documentation box was created in the electronic health record by a facility IT 
representative within the visual screening assessment screen to mark “pass” or “refer” based on 
the child’s screening results from the PlusOptix™. If a child received a “refer”, he/she was 
referred to ophthalmology onsite for further visual exam to confirm if there was a true refractive 
error identified.  
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Flowsheets were created by the project manager to collect screening results for pre- and 
post-implementation and to de-identify personal health information (PHI). Nursing staff 
documented screening results from the PlusOptix™ along with the medical record number and 
date of birth on the flowsheets. The project manager used the flowsheets to review the chart, 
screening results, and any follow-up ophthalmology results that were obtained. A flowsheet was 
also created to document the same information from the pre-implementation group.  
Data were collected over three months using the PlusOptix™ screener in the designated 
age groups, during well-child check-ups, provided by two of the providers within the Midwest 
facility. One-hundred-sixty-one children were identified in the post-implementation group over 
the 3 months. Once the post-implementation group number of children was determined to be n 
= 161, the same number of patient charts were randomly pulled from EHR by IT, using the 
same parameters for age, well-child check-up, and provider as post-implementation. The initial 
number of well-child check-ups was unknown. It was anticipated there would be at least 100 in 
the sample size. One-hundred-sixty-one check-ups were done during the three months, 
therefore, that became the recruitment number for each the pre- and post-implementation 
samples.  
No release of information was obtained as only chart data were collected. Children were 
referred to onsite ophthalmology so the project manager could follow ophthalmology results 
through the EHR. No parents were contacted to remind them to follow-up with ophthalmology or 
contacted to see if they had followed up with ophthalmology at an outside facility. 
Evaluation, the final phase of the SM, involves assessing the new plan of practice to 
ensure goals were met, monitor for any adverse occurrences, identify any changes that need to 
be made, and how to continue. The evaluation process is a continuous process. The project 
manager was easily available on site or via cell phone to help monitor nursing staff to make sure 
screenings were being performed appropriately. Lighting and distance parameters had to be 
maintained during screenings to assure an accurate screening result by the PlusOptix™. The 
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project manager was also available for any trouble shooting, questions with the flowsheets, and 
reviewing EHR weekly to make sure screenings were getting documented appropriately.  
Strengths and Limitations of the EBP Project 
Strengths 
 Involvement of the providers and administration from the beginning of this EBP project 
implementation process was advantageous. Administration was onboard due to evidence from 
the literature showing high sensitivity and specificity of AVS. Other facilities within the 
community were starting to use AVS and the EBP project facility makes it a priority to stay 
abreast of new technologies and what is being used within the local community to help stay 
competitive. The EBP facility also prides itself on research which lent a hand to implementation 
of this project and support. Providers within the facility were also very interested in the results 
that were being obtained from the PlusOptix™ and how it compared to screening methods prior 
to its use.  
 Nursing staff at the EBP project facility was very helpful in the implementation process of 
the AVS within the clinic setting. The staff was in frequent communication with the project 
manager about how the AVS use in clinic was going.  
There were many that helped make this EBP project a success. The IT specialist which 
assisted in gathering EHR information was a great help and resource for this EBP project. He 
was able to capture EHR that fit the parameters of the project so the project manager could 
gather pre-implementation data. He also helped retrieve EHR for the post-implementation group 
so the project could start on time at the beginning of October. Facility IRB was not approved to 
collect data on the EBP project until the beginning of November. The facility IRB and Valparaiso 
IRB gave approval to collect data from the EHR dating back to the beginning of October when 
the AVS were first being used.  
Assistance was received from the director of research at the EBP project site and with a 
statistician consult on the use of SPSS and data results.  
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Parents bringing their children in for a well-child check-up in the specified age groups for 
screenings were very receptive and even intrigued by the use of an AVS. Parents were 
informed and educated on the use of the PlusOptix™ and different refractive errors it could 
detect.  
Visual screenings were faster and easier for nursing staff to perform using the PlusOptix. 
Children were very cooperative with the visual screenings due to a picture on the machine, the 
“warble” sound it makes, the quickness of the screening, and that the child was not confined 
during the screening. 
The PlusOptix Inc™ representative for the area where the EBP facility was located was 
very helpful and readily available via email. She provided the initial education on the 
PlusOptix™, its use, trouble shooting, results interpretation, and maintenance. She was 
available to the project manager to educate on how to perform calculations using the results 
from the PlusOptix™ in order to see why the child was being referred to ophthalmology. 
Limitations 
Limitations to this EBP project included incomplete documentation by nursing staff for 
several children which resulted in no screening results. The screening technique/routine was 
new for the nursing staff and documentation within the EHR changed from the previous 
processes. Having a float nurse from another clinic or prn staff that was not aware of the data 
collection system also contributed to no screening results. All regular nursing staff at the EBP 
facility were aware of the data collection and were trained in the use of the flowsheets and 
which provider patient population was being used. However, prn staff and staff from the other 
five facilities were not aware of the data collection process. If the project manager was not 
onsite the day prn staff or staff from another clinic worked, they were not always made of aware 
of the data collection process on the flow sheets. In the future, prn staff and any float staff could 
be given a folder with the data collection information to help decrease missed screening 
documentation on flow sheets.  
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Not all children completed follow-up with ophthalmology to further support sensitivity of 
the PlusOptix™ or contribute to specificity results. No release of information was obtained from 
those being screened and only chart data were collected. Therefore, parents were not contacted 
and reminded to follow-up with ophthalmology or to check if they had followed-up with 
ophthalmology at an outside facility. When performing a project like this in the future, the project 
manager would recommend release of information be obtained when implementing the project. 
Then parents could be contacted to encourage follow-up appointments with ophthalmology 
referrals leading to more data to further confirm sensitivity of the PlusOptix.  
Specificity was not obtainable for this EBP project as not all children who completed the 
visual screening were sent to ophthalmology to confirm the absence of disease. This situation 
was due to time and funding limitations. However, there were data within the literature to show 
high specificity of AVS. A time-frame of three months was implemented for this EBP project and 
there was no funding to cover ophthalmology screenings without a referring diagnosis.  
Implications for the Future 
Practice 
The USPSTF reports 1% to 5% of U.S preschool aged children have some sort of visual 
impairment (USPSTF 2011), and the AAP, AAPOS, AAO, and AACO (2003) recommend visual 
screenings starting in newborns then with every well-child check-up visit thereafter. It is 
important for advanced practice registered nurses (APRN), as well as all providers, to stay 
abreast of new research regarding health promotion and illness prevention such as visual 
screenings. By implementing the most up to date recommendations, APRN’s are able to offer 
the best care and information to help mitigate chronic diseases.  
It is important for APRN’s and nurses to develop a strategy to communicate with parents 
regarding the importance of health maintenance, such as regular visual screenings and follow-
up with ophthalmology for any abnormal findings. This will help aid in health promotion.   
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Automated visual screeners, such as the PlusOptix™ have greater sensitivity and referral rates 
than visual screenings performed by providers alone during a well-child check-up. Therefore, 
AVS should be considered for implementation in pre-school age children screenings performed 
by nursing staff during well-child check-ups and in many different settings  
Theory 
The Health Promotion Model (HPM) postulates that specific behaviors and cognitions 
are directly related to individual health promotion behaviors (Friedman, Bowden, & Jones, 
2003). An individual’s prior behavior as well as inherited and acquired characteristics have great 
impact on the individual’s prior behavior. The inherited and acquired characteristics have a great 
impact on the individual’s beliefs, affect, and how the individual views health promoting 
behaviors. The pre-school age group is not yet able to have their own views about health 
promoting behaviors, but by teaching parents these behaviors they can be passed down to their 
children. Therefore, it is important to create positive affects in the individual’s beliefs and health 
promotion behaviors to pass down to future generations.  
The HPM allows for ease of applicability by its simplistic stepwise approach and was 
intended for any individual in any situation other than the illness state. These features of the 
HPM make it very adaptable in the health promotion, disease prevention setting, and a good 
model for APN’s and nurses to follow when implementing new screening techniques such as 
AVS. If a family perceives a threat and there are opportunities for decreasing that threat, such 
as vision screenings, the family will be more likely to act on it. When providing information, 
parents will be able to actively own the behavior of early vision screening.   
Research 
Further research and education is needed to continue to show sensitivity and specificity 
of AVS and then be disseminated to primary providers. Research with funding is needed so all 
those within the recruited population can be screened both with an AVS and then with 
ophthalmology to show those confirmed to have disease (sensitivity) and those without disease 
SCREENING AMBLYOPIC FACTORS 75 
 75 
(specificity). More research is needed in a variety of settings using AVS to better show their 
ability to be effective at detecting refractive errors, especially in the very young preschool ages.  
Education 
 Continued education is needed for APN’s, nurses, and all healthcare providers on the 
importance of early vision screening as recommended by the USPSTF and other organizations. 
In order to get this education out there, continued research with its results and projects such as 
this EBP project need to be published and disseminated to all providers and facilities who 
provide visual screenings. AVS are reliable, easy to use, highly sensitive pieces of equipment 
that should be available in many different settings. Dissemination of information can include 
research conferences, nursing conferences, advanced practice conferences, and manuscript 
publishing of findings. Also, organizations such as the Lion’s Club, who advocate for good vision 
programs and help with vision screenings in many communities, are a good resource to help in 
purchasing AVS. AVS are expensive but there are many organizations that are willing to help 
with various health promotion activities, such as screenings, to help gather funding for new 
screening equipment. It is important for APRN’s and nurses to continue to educate the 
communities in which they serve about the importance of wellness and health promotion. By 
attending yearly well exams, chronic disease can be diminished and better outcomes 
accomplished. APRN’s and nurses also need to continue their own education by staying abreast 
of new research being done and printed in the literature and also by attending conferences with 
up-to-date information. Being informed better prepares APN’s and nurses to promote health and 
wellness to their community.   
Conclusion 
 In conclusion, the goal of this EBP project was to implement an AVS, the PlusOptix™, in 
a Midwest pediatric clinic for visual screenings as AVS were shown in the literature to have high 
sensitivity and specificity to detect refractive errors. Findings from this EBP project 
demonstrated that AVS can statistically improve the detection rate of refractive errors in 9-
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month, 24-month, 36-month, and 48-month-old children. Data showed a referral rate of 1.3% in 
the pre-implementation group. A referral rate of 11.3% was revealed in the post-implementation 
group with a sensitivity of 100%. Findings from this EBP project were similar to that reported in 
the literature and answered the PICOT question: will an automated visual screener detect more 
refractive errors than traditional visual exams performed by pediatric providers during routine 
well-child checks. The Plusoptix™ found more refractive errors than traditional visual exams in 
this pediatric population. Thus, primary care providers should consider implementing AVS into 
their routine well-child check-ups for young children who are pre-verbal and those populations 
with behavioral or developmental disabilities, as they are a great asset to detect and mitigate 
visual abnormalities. 
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EHR: Electronic Health Record 
EPC: Oregon Evidence-based Practice Center 
HPM: Health Promotion Model 
IDN: Identification Number 
PCP: Primary Care Provider(s) 
PHI: Protected Health Information 
PPV: Positive Predictive Value 
SM: Stetler Model 
USPSTF: US Preventive Services Task Force 
WCC: Well Child Check(s) 
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APPENDIX A 
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APPENDIX B 
Quick reference guide - Vision Screener plusoptiX S12C 
Thank you for choosing plusoptiX S12C. An award winning, 4th generation vision screening device.  This quick 
reference guide will support you in performing your first vision screening in 8 easy steps: 
Ensure that the batteries are inserted with the 
proper orientation. Follow the guide in the 
battery compartment. Then close the lid. Press 
On/Off button to switch device on. 
Choose date and time format by touching the 
appropriate buttons on screen. Then set date 
and time using the arrow buttons. Confirm with 
green checkmark button to proceed to start 
screen. Select age group of patient by touching 
appropriate button on screen. 
The patient needs to fixate on camera lens. Level  
camera to patient’s eyes and press shutter to see  
camera picture on screen. 
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Tilt camera so that screen is inclined by 
45 degrees.  Avoid sunlight and 
distractions. Adjust room light to  
obtain proper pupil size of 4 to 8mm. 
Identify 
right measurement distance by observing camera picture on 
screen. Start at 4 feet. Camera  picture is blurred. Move closer 
until picture is in clear  focus. A warble sound is being played 
and  measurement starts automatically. 
Distance too far: Pupils crowded in white squares 
Right distance: Pupils circled in green  
Distance too close: Pupils almost do not fit onto screen 
Step 6 
A ping sound is played at the end of a 
measurement. Camera picture freezes and a 
green “pass” or red “refer” screening result is 
shown on screen. Use orange arrow buttons to 
toggle  in between result screens. 
Step 7 
A “pass” vision screening result indicates that all readings  are 
below the referral thresholds, i.e. are in normal range. 
In some cases an error message will be displayed on screen. In this case vision  screening 
result is inconclusive. Review user manual for hints on how to avoid an  aborted 
measurement and retry. If error message reads “measurement incomplete”  in two 
consecutive attempts, vision screening result is deemed to be “refer”. 
A “refer” vision screening  result indicates that 
one or  more readings are at or  above referral 
thresholds.  These patients need to be  sent to an 
eye care professional   
for a comprehensive eye exam. Pass Picture out  
Refer of focus 
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Step 8 
In settings you will find five validated sets of referral  
thresholds to choose from. They range from very  
sensitive (and less specific) to very specific   
Access  Access referral  (and less sensitive). settings threshold settings 
Pay attention to the description provided on  screen 
and access on screen help to review  referral 
thresholds in detail. 
Please note: 
Children with glasses are already under the care of an eye care professional and therefore need not be screened. If your program  requires 
screening of children with glasses then the child should be screened wearing the glasses and the glasses should be tilted  up at the temples to 
reduce glare. 
Plusoptix devices are specifically designed for the purpose of detecting the most common vision disorders in toddlers and preschool children. 
The screening of adults is only valid to identify the possibility of refractive error (need for glasses).  Adults should receive comprehensive eye 
examinations to detect early stages of age related eye diseases. The methods used for children’s screening  are not able to detect adult 
eye/vision diseases. 
These steps as well as all other features of your device are explained in detail in the user manual.  The 
user manual describes error messages and fixes in detail, too. In case you don’t have a copy  of the user 
manual, you can download it here:  
www.plusoptix.com/images/plusoptix/doku/usermanualS12USA.pdf 
Once the device is switched on, you have access to additional information by  
touching the blue “i” icon located at the bottom right corner of each screen.  This 
button opens an on screen help page. 
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APPENDIX C 
Post-Implementation Data Flow Sheet 
 
Medical Record 
Number 
 
Date of Birth 
 
PlusOptix Results 
 
 
ID Number 
   1 
   2 
   3 
   4 
   5 
   6 
  
 
 7 
   8 
   9 
   10 
   11 
   12 
   13 
   14 
   15 
   16 
   17 
   18 
   19 
   20 
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APPENDIX D 
De-identified Post-Implementation Flow Sheet 
 
ID 
Number 
 
Date of Birth 
 
PlusOptix  
 Results 
 
 
Ophthalmology 
Results 
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APPENDIX E 
Pre-Implementation Data Flow Sheet 
 
Medical Record 
Number 
 
Date of Birth 
 
Traditional 
Screening 
(pre-
implementation) 
 
 
ID Number 
   1 
   2 
   3 
   4 
   5 
   6 
  
 
 7 
   8 
   9 
   10 
   11 
   12 
   13 
   14 
   15 
   16 
   17 
   18 
   19 
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APPENDIX F 
De-Identified Pre-Implementation Data Flow Sheet 
 
ID  
Number 
 
Date of Birth 
 
Traditional  
Results 
 
 
Ophthalmology  
Results 
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